Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1A (migalastat)1件: Migalastat1件: D10359 --1件: 19
2A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: D00276 ,
D00278 ,
D00424 		--1件: 96
3A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)----1件: 60
4A multistrain probiotic product (DSF)----1件: 97
5A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs----1件: 46
6A novel synthetic, orally-administered, non-peptide small molecule, which acts as----1件: 254
7A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R)----1件: 51
8A single booster dose of the Moderna mRNA COVID-19 vaccine----1件: 28
9A-1293543.74----1件: 96
10A-623----1件: 49
11A-623 or AMG 623----1件: 66
12A-dopamine1件: Dopamine2件: D00633 ,
D07870 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
13A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299
14A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
15A01AC02----1件: 28
16A042917017----1件: 21
17A04AD10----1件: 298
18A07DA03----1件: 97
19A07EA06----1件: 66
20A10BK03----1件: 65
21A11HA02----1件: 93
22A16AB04----1件: 19
23A16AX06----1件: 19
24A16AX07----1件: 240
25A4250----4件: 93, 296, 297, 338
26A4250 (1200 µg)----1件: 338
27A4250 (200 µg)----1件: 338
28A4250 (400 µg)----1件: 338
29A4250 (600 µg)----1件: 338
30A4250 (odevixibat)1件: Odevixibat1件: D11716 1件: SLC10A2 💬1件: Bile secretion 💬1件: 338
31A4250-015----1件: 297
32A4I Antagonist----1件: 13
33A: 1 dosis----1件: 97
34A: PTH (1-84)----1件: 235
35AAC Hexal----1件: 299
36Aadipose-Derived Mesenchymal Stem Cells----1件: 6
37AAV BBP-631----1件: 81
38AAV directed hLDLR gene therapy----1件: 79
39AAV-RPGR----1件: 90
40AAV1-gamma-sarcoglycan vector injection----1件: 113
41AAV2-GDNF----1件: 6
42AAV2-GDNF gene therapy----1件: 17
43AAV2-REP1----1件: 90
44AAV2/5-hPDE6B----1件: 90
45AAV2/5-hRKp.RPGR----1件: 90
46AAV2/8.TBG.hARSB----1件: 19
47AAV2/8LSPhGAA----1件: 256
48AAV2CUhCLN2 (3x10^12 particle units)----1件: 19
49AAV5-HRKP.RPGR----1件: 90
50AAV8-RPGR----1件: 90
51AAV8.TBG.hLDLR----1件: 79
52AAV9 BBP-812----1件: 307
53AAV9-CAG-coh-SGSH----1件: 19
54AAV9-GLB1----1件: 19
55AAVrh.10-hMPSIIIA----1件: 19
56AAVrh.10cuARSA----1件: 19
57AAVrh.10CUCLN2----1件: 19
58AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies----1件: 19
59AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies----1件: 19
60AB (antibiotics)----1件: 97
61AB 1003----1件: 2
62AB1010----6件: 2, 5, 6, 13, 46, 96
63ABA, open-label (OL)----1件: 46
64Abacavir1件: Abacavir2件: D00891 ,
D07057 		--4件: 2, 135, 265, 325
65Abacavir (ABC)1件: Abacavir2件: D00891 ,
D07057 		--1件: 325
66Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT)3件: Abacavir,
Lamivudine,
Zidovudine		4件: D00353 ,
D00413 ,
D00891 ,
D07057 		--1件: 325
67Abacavir 300mg twice daily1件: Abacavir2件: D00891 ,
D07057 		--1件: 265
68Abacavir sulfate2件: Abacavir,
Sulfate ion		2件: D00891 ,
D07057 		--1件: 265
69Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		4件: D00353 ,
D00413 ,
D00891 ,
D07057 		--1件: 265
70Abalimumab----1件: 97
71Abalimumab bio-originatore----1件: 107
72Abatacept1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300
73Abatacept (ABA)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 97
74Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)2件: Abatacept,
Methotrexate		3件: D00142 ,
D02115 ,
D03203 		4件: CD80,
CD86,
DHFR,
DHFR2 💬		17件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
75Abatacept (BMS-188667)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
76Abatacept (CTLA4-Ig)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 44
77Abatacept (IV)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
78Abatacept (SC)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
79Abatacept + csDMARD1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
80Abatacept + Methotrexate2件: Abatacept,
Methotrexate		3件: D00142 ,
D02115 ,
D03203 		4件: CD80,
CD86,
DHFR,
DHFR2 💬		17件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
81Abatacept + Vaccines1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
82Abatacept Active Treatment1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 50
83Abatacept also known as Orencia also known as CTLA4-Ig1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 49
84Abatacept combination product (ACP)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
85Abatacept Delayed-Onset Treatment1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 50
86Abatacept Injection1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬3件: 11, 46, 107
87Abatacept Placebo1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬2件: 46, 53
88Abatacept Prefilled Syringe1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
89Abatacept SC1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 53
90Abatacept subcutaneous1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 50
91Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab,
Tocilizumab		3件: D02596 ,
D02994 ,
D03203 		4件: CD80,
CD86,
IL6R,
MS4A1 💬		24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
92ABBV-006----1件: 97
93ABBV-066----2件: 96, 97
94ABBV-0805----1件: 6
95ABBV-105----2件: 46, 49
96ABBV-105, A-1519938.0----1件: 46
97ABBV-119----1件: 299
98ABBV-154----2件: 46, 96
99ABBV-2222----1件: 299
100ABBV-257----1件: 46
101ABBV-3067----1件: 299
102ABBV-323----2件: 53, 97
103ABBV-323 Dose A----1件: 97
104ABBV-323 Dose B----1件: 97
105ABBV-3373----1件: 46
106ABBV-8E12----2件: 5, 7
107ABBV-951----1件: 6
108ABBV-CLS-7262----1件: 2
109ABC----2件: 265, 325
110ABC008----1件: 15
111Abcertin----1件: 19
112Abdominal compression----2件: 6, 17
113Abdominal ultrasound----1件: 231
114ABELCET1件: Amphotericin B1件: D00203 --1件: 299
115Abelmoschus manihot----1件: 66
116Abemaciclib1件: Abemaciclib1件: D10688 2件: CDK4,
CDK6 💬		29件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Endocrine resistance, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬1件: 34
117Abetimus1件: Abetimus---1件: 49
118ABETIMUS SODIUM1件: Abetimus---1件: 49
119Abetimus sodium (LJP 394)1件: Abetimus---1件: 49
120AbGn-168H----1件: 97
121ABH0011件: ABH001---1件: 36
122ABI-009, nab-rapamycin, albumin-bound rapamycin1件: Sirolimus1件: D00753 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 86
123ABI-M201----1件: 97
124Abiraterone1件: Abiraterone---2件: 75, 81
125Abiraterone Acetate2件: Abiraterone,
Acetate		---2件: 75, 81
126Abiraterone acetato1件: Abiraterone---1件: 75
127Abituzumab1件: Abituzumab---1件: 51
128Abituzumab 1500 mg1件: Abituzumab---1件: 51
129Abituzumab 500 mg1件: Abituzumab---1件: 51
130ABO-101----1件: 19
131ABO-102----1件: 19
132Abobotulinumtoxin A----1件: 13
133ABP 501----1件: 46
134ABP 710----1件: 46
135ABP 710 - Biosimilar to infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
136ABP 798----1件: 46
137ABP 798 - Biosimilar to rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
138ABP 798 Biosimilar to Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
139ABP 959----1件: 62
140ABP 959 - biosimilar to eculizumab1件: Eculizumab1件: D03940 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62
141ABP 959 - proposed biosimilar to eculizumab1件: Eculizumab1件: D03940 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62
142ABPC1件: Ampicillin3件: D00204 ,
D01251 ,
D02119 		--1件: 84
143ABR-215062----1件: 13
144ABR-215062 sodium salt----2件: 13, 96
145ABR-215757----2件: 49, 51
146Abrilumab1件: Abrilumab1件: D10540 2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97
147ABT 494----1件: 46
148ABT 494 12mg----2件: 46, 96
149ABT 494 3mg----2件: 46, 96
150ABT Humira----1件: 96
151ABT-122----1件: 46
152ABT-199----1件: 49
153ABT-494----7件: 41, 46, 49, 96, 97, 107, 271
154ABT-494 15mg----1件: 46
155ABT-494 30mg----1件: 46
156ABT-555----1件: 13
157ABT-874----1件: 96
158ABT-874/Human monoclonal antibody against IL-12----1件: 13
159ABT-Humira1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97
160ABT-SLV187----1件: 6
161ABX-14311件: ABX-1431---1件: 13
162ABX-1431 HCl1件: ABX-1431---1件: 13
163ABX464----3件: 46, 96, 97
164ABX464 100mg----2件: 46, 97
165ABX464 25mg----1件: 97
166ABX464 50mg----2件: 46, 97
167ABY-035----1件: 271
168AC-203----1件: 36
169AC-203 1% Topical Ointment----1件: 162
170AC0058TA----1件: 49
171AC430----1件: 46
172Acalabrutinib1件: Acalabrutinib1件: D10893 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 46, 61
173Acamprosate1件: Acamprosate2件: D02780 ,
D07058 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 206
174Acarbose1件: Acarbose1件: D00216 5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298
175Acazicolcept----1件: 49
176ACC----1件: 299
177ACC600Tabs----1件: 299
178Accelerated 1 hour-infusion----2件: 96, 97
179Accelerated 30 minutes-infusion----2件: 96, 97
180Accelerometer----1件: 17
181Access program - sildenafil citrate, Viagra, Revatio1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
182Accordion Pill Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
183Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
184Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
185Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
186Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
187Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
188Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
189Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
190Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
191Accupro----1件: 19
192Accuretic1件: Quinapril2件: D00459 ,
D03752 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 19
193ACE I, ATA II and Statins----1件: 218
194ACE inhibitor----1件: 66
195ACE inhibitor + statin----1件: 66
196ACE Inhibitor or Angiotensin receptor antagonist1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66
197ACE-011----1件: 86
198ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113
199ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113
200ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113
201ACE-031 0.5 mg/kg q4wk----1件: 113
202ACE-031 1.0 mg/kg q2wk----1件: 113
203ACE-083----2件: 10, 113
204ACE-1334----1件: 51
205ACE-inhibitor----1件: 218
206ACE/ARB----1件: 66
207Acebilustat1件: Acebilustat---1件: 299
208Aceclofenac1件: Aceclofenac1件: D01545 3件: PTGES,
PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
209ACEi----2件: 66, 224
210ACEI/ARB and corticosteroids----1件: 66
211Acellbia----1件: 46
212ACENEURAMIC ACID1件: Aceneuramic acid1件: D11016 --1件: 30
213Aceneuramic Acid Extended-Release1件: Aceneuramic acid1件: D11016 --1件: 30
214Aceneuramic acid extended-release (Ace-ER)1件: Aceneuramic acid1件: D11016 --1件: 30
215Aceneuramic Acid Extended-Release Tablets1件: Aceneuramic acid1件: D11016 --1件: 30
216Acetamide1件: Acetamide---2件: 86, 154
217Acetaminophen1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬16件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337
218Acetaminophen Tab 650mg1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
219Acetaminophen tablets1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
220Acetaminophen/paracetamol1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 35, 49
221Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
222ACETATO DI AMMONIO----1件: 97
223Acetazolamide1件: Acetazolamide2件: D00218 ,
D01196 		13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬6件: 13, 90, 115, 155, 225, 230
224Acetazolamide Sandoz 2501件: Acetazolamide2件: D00218 ,
D01196 		13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 225
225Acetic acid1件: Acetic acid1件: D00010 --1件: 97
226Acetohydroxamic Acid1件: Acetohydroxamic acid1件: D00220 --1件: 251
227Acetohydroxamic Acid Oral Tablet [Lithostat]1件: Acetohydroxamic acid1件: D00220 --1件: 251
228Acetominofene----2件: 11, 63
229Acetominophen----1件: 63
230ACETYL- L- CARNITINE1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--1件: 265
231Acetyl-L-carnitine2件: Acetylcarnitine,
Levocarnitine		3件: D02030 ,
D02176 ,
D04713 		--1件: 298
232Acetyl-L-carnitine 1000mg 2X per day for 3 months2件: Acetylcarnitine,
Levocarnitine		3件: D02030 ,
D02176 ,
D04713 		--1件: 298
233Acetylcarnitine1件: Acetylcarnitine---2件: 2, 265
234Acetylcholine1件: Acetylcholine---1件: 11
235Acetylcysteine1件: Acetylcysteine1件: D00221 --20件: 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
236Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: D00221 --1件: 85
237ACETYLCYSTEINE SODIUM1件: Acetylcysteine1件: D00221 --1件: 299
238ACETYLSALICYLIC ACID1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210
239Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
240ACH-0144471----2件: 62, 222
241ACH-0144471 compresse----1件: 222
242ACH-0145228----1件: 62
243ACH0144471----1件: 222
244ACH0144471 compresse----1件: 222
245ACHIM as solute (10^9 intestinal microbes/ml)----1件: 51
246Aciclin----1件: 28
247Aciclovir1件: Acyclovir1件: D00222 --3件: 13, 28, 60
248Acid mycophenolic (Myfortic)1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬1件: 222
249Acide folique1件: Folic acid1件: D00070 --1件: 46
250ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299
251ACIDO ASCORBICO----1件: 10
252ACIDO ASCORBICO DC.IT----1件: 10
253ACIDO DEOSSICOLICO----1件: 94
254Acido Micofenolico1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬1件: 49
255Acido Obeticolico----2件: 93, 94
256Acido Sialico - Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: D11016 --1件: 30
257ACIDO TAUROURSODESOSSICOLICO----1件: 2
258Acido ursodessicolico----1件: 93
259Acidophilus1件: Lactobacillus acidophilus1件: D04349 --1件: 97
260Acidum ascorbicum1件: Ascorbic acid1件: D00018 --1件: 206
261ACIDUM ASCORBICUM D61件: Ascorbic acid1件: D00018 --1件: 206
262Acipimox1件: Acipimox1件: D07190 --2件: 78, 265
263Acitretin1件: Acitretin1件: D02754 5件: RARA,
RARB,
RXRA,
RXRB,
RXRG 💬		19件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 37
264Aclasta----3件: 13, 271, 274
265Aclasta 5 mg Infusionslösung1件: Zoledronic acid4件: D01968 ,
D06378 ,
D06379 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13
266Aclasta 5mg solution for infusion----1件: 13
267ACM----1件: 49
268ACN00177----1件: 337
269Acomplia1件: Rimonabant1件: D05731 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193
270ACOMPLIA 20 mg film-coated tablets1件: Rimonabant1件: D05731 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193
271Acoramidis----1件: 28
272Acotiamide1件: Acotiamide---1件: 51
273Acoziborole----1件: 65
274Acoziborole (SCYX-7158)1件: SCYX-7158---1件: 65
275ACP-001----1件: 78
276ACP-001 (TransCon hGH)----1件: 78
277ACP-011----1件: 78
278ACP-103----1件: 6
279ACR16----1件: 8
280ACR16 10 mg----1件: 8
281ACR16 22.5 mg----1件: 8
282ACR16 45 mg----1件: 8
283ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8
284ACR3251件: ACR325---1件: 6
285ACT----1件: 13
286ACT - 064992----1件: 86
287ACT-050089----1件: 86
288ACT-050089 (Ro 61-0612)----1件: 86
289ACT-064992----5件: 51, 85, 86, 88, 210
290ACT-064992 (macitentan)1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
291ACT-064992 / JNJ-67896062----1件: 86
292ACT-064992/ JNJ-67896062----1件: 86
293ACT-064992D----1件: 86
294ACT-1----1件: 13
295ACT-128800----1件: 13
296ACT-128800 Dose 1----1件: 13
297ACT-128800 Dose 2----1件: 13
298ACT-128800 Dose 3----1件: 13
299ACT-178418----1件: 86
300ACT-293987----3件: 51, 86, 88
301ACT-293987 (NS-304)----1件: 86
302ACT-293987 / JNJ-67896049----1件: 84
303ACT-334441----1件: 49
304ACT-385781A----1件: 86
305ACT-385781A (Actelion Epoprostenol)1件: Epoprostenol2件: D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
306ACT-434964----1件: 19
307Act-HiB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 14, 61, 62, 222
308ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 61, 62
309Actemra1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
310Actemra(EU-licensed)1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
311Actemra, MRA1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107
312Acteoside1件: Acteoside---1件: 66
313ACTH1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 13, 66, 145, 193, 222
314ACTH (Acthar) Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66
315Acthar1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222
316Acthar 80 unit injection1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66
317Acthar Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 46, 49, 50, 84, 222
318ACTHAR Gel (ACTH)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
319ACTHAR Gel (adrenocorticotropic hormone)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
320ACTHAR Gel 40 units twice weekly1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
321ACTHAR Gel 80 units twice weekly.1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
322Acthar high dose (80 U)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49
323Acthar Injectable Product1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 46
324Acthar low dose (40 U)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49
325ActHIB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66
326ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66
327Acthrel1件: Corticorelin ovine triflutate1件: D03592 2件: CRHR1,
CRHR2 💬		4件: Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
328ACTIMMUNE1件: Interferon gamma-1b1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 326
329Actimmune Registry1件: Interferon gamma-1b1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 326
330ActiMyo recording----1件: 6
331Activated smart device----1件: 299
332Active BMN 111: Daily subcutaneous injection of 15 ug/kg of BMN 111----1件: 276
333Active comparator----2件: 6, 46
334Active Comparator receiving Extavia®1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
335Active Control----1件: 13
336Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6
337Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin---1件: 6
338Active Investigational Treatment ENT-01----1件: 6
339Active Stimulation----1件: 46
340Active tDCS----1件: 6
341Active topical NS2 1% dermatologic cream----1件: 160
342Active tPCS----1件: 6
343Active Treatment Group 7% Hypertonic Saline----1件: 299
344Activity Monitor1件: Methamidophos---1件: 113
345Actonel 5mg Film Coated Tablets1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
346Actonel Once a Week 35 mg film-coated tablets1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
347Actonel Once a week 5mg film coated tablets1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113
348Actonel/Optinate 5mg film-coated tablets1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
349ACTOS (Pioglitazone)1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 13
350Actos 15 mg1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
351Actos 30 mg1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
352Actos 45 mg1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
353Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299
354Actrapid Penfill 100UI/ml----1件: 299
355ActRIIA-IgG1Fc----1件: 86
356ACU-4429----1件: 301
357Acupuncture----2件: 46, 70
358Acute Antioxidant----1件: 299
359Acycloguanosine1件: Acyclovir1件: D00222 --2件: 46, 53
360Acyclovir1件: Acyclovir1件: D00222 --2件: 13, 28
361Acylated and unacylated ghrelin dosages1件: Lenomorelin---3件: 193, 201, 202
362ACZ885----7件: 46, 84, 106, 107, 108, 266, 267
363ACZ885 (investigational)----1件: 46
364ACZ885 150 mg (Canakinumab)1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 107
365ACZ885 Drug Substance----3件: 46, 106, 107
366ACZ885, 150mg/1.0ml----2件: 266, 267
367ACZ885D----1件: 108
368ACZ885G----1件: 107
369AD 452----1件: 46
370AD 452 18 mg tablet----1件: 46
371AD 452 4.5 mg Tablet----1件: 46
372AD 452 9 mg tablet----1件: 46
373AD-810N (zonisamide)1件: Zonisamide1件: D00538 8件: CACNA1G,
CACNA1H,
CACNA1I,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬1件: 6
374AD-MSC transdifferentiated HSCs (AD-HSCs)----1件: 60
375Ad26.COV2-S.02----1件: 299
376Ad26.COV2.S----5件: 13, 35, 46, 49, 51
377ADA gene transfer----1件: 65
378ADA PBSC----1件: 65
379ADA Umbilical Cord Blood Cells----1件: 65
380Adagen1件: Pegademase1件: D05384 --1件: 65
381Adalimuab, Etanercept, Tocilizumab, or Abatacept3件: Abatacept,
Etanercept,
Tocilizumab		3件: D00742 ,
D02596 ,
D03203 		5件: CD80,
CD86,
IL6R,
LTA,
TNF 💬		79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
382Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬18件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271
383Adalimumab (20mg)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
384Adalimumab (40 mg)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
385Adalimumab (40mg)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
386Adalimumab (ADA)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
387Adalimumab (D2E7)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 271
388Adalimumab (Humira)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 222, 271
389Adalimumab (HUMIRA®)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
390Adalimumab (up to 9 months exposure)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
391Adalimumab - GP20171件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
392Adalimumab - US licensed Humira1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
393Adalimumab 40 mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
394Adalimumab 40 mg eow or ew1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
395Adalimumab 40 mg sc every other week1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
396Adalimumab 40 mg subcutaneous (SC) every other week (EOW)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
397Adalimumab 40mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
398Adalimumab 40mg q2w1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
399Adalimumab 80 mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
400Adalimumab and Infliximab2件: Adalimumab,
Infliximab		2件: D02597 ,
D02598 		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
401Adalimumab and its biosimilars1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
402Adalimumab biosimilare1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
403Adalimumab delivered in current autoinjector1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
404Adalimumab delivered in current syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
405Adalimumab delivered in Physiolis autoinjector1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
406Adalimumab delivered in Physiolis syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
407ADALIMUMAB HUMIRA1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
408Adalimumab Injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 40, 46, 96
409Adalimumab Injection [Humira]1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 19
410Adalimumab PFS and Pen1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
411Adalimumab PRN1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
412Adalimumab with methotrexate2件: Adalimumab,
Methotrexate		3件: D00142 ,
D02115 ,
D02597 		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
413Adalimumab, current formulation1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
414Adalimumab, Etanercept, Golimumab or infliximab4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: D00742 ,
D02597 ,
D02598 ,
D04358 		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
415Adalimumab, new formulation1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
416Adalimumab, plus prednisone2件: Adalimumab,
Prednisone		2件: D00473 ,
D02597 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
417Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
418ADALIMUMAB-EU1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
419Adalimumab-Pfizer1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
420Adalimummab----1件: 46
421Adaptor: Hakko Adaptor----1件: 6
422Adcirca1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
423ADCIRCA 20 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
424Adcirca®1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
425Adderall XR----1件: 13
426Adderall XR 10 mg----1件: 13
427Adderall XR 5mg----1件: 13
428Adefovir1件: Adefovir1件: D02768 --1件: 46
429Adempas1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299
430Adempas (active agent riociguat)1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88
431Adempas (Riociguat, BAY63-2521)1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88
432ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
433ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
434ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
435ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
436ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
437Adempas 0.125 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299
438Adempas 0.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
439Adempas 0.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
440Adempas 1 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
441Adempas 1.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
442Adempas 1.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
443Adempas 1.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
444Adempas 2 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
445Adempas 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
446Adempas 2.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
447Adempas 2.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
448Adempas®1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88
449Adempas® 0.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
450Adempas® 1.0 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
451Adempas® 1.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
452Adempas® 2.0 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
453Adempas® 2.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
454Adempas¿ 0.5 mg compressa rivestita con film1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
455Adempas¿ 1.01件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
456Adempas¿ 1.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
457Adempas¿ 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
458Adempas¿ 2.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
459Adenin1件: Adenine1件: D00034 --1件: 46
460ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE1件: Levothyroxine2件: D01010 ,
D08125 		2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 19
461Adeno-associated viral vector serotype 3B encoding shortened human ATP7B----1件: 171
462Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113
463Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113
464Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene----1件: 19
465Adeno-associated viral vector serotype 9 encoding human ATP7B----1件: 171
466Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal)----1件: 19
467Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal)----1件: 19
468Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
469Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector1件: Idursulfase1件: D04499 1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
470Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector----1件: 19
471Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector----1件: 19
472Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector----1件: 19
473ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE----1件: 8
474Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113
475Adeno-associated virus serotype hu68 containing the human GALC gene----1件: 19
476Adeno-associated virus serotype rh.10 expressing beta-galactosidase1件: Tilactase1件: D03348 --1件: 19
477ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113
478Adeno-associated virus type 2 vector encoding Rab escort protein 1----1件: 90
479Adeno-associated virus-CFTR vector----1件: 299
480Adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65
481Adipate1件: Iron (III) oxide adipate---2件: 97, 228
482Adipose derived mesenchymal stem cell----1件: 3
483Adipose derived mesenchymal stem cells----1件: 86
484Adipose derived mesenchymal stem cells ( AD-MSCs)----1件: 60
485Adipose derived stromal cells intravenously injected----1件: 39
486Adipose derived, autologous mesenchymal stem cells----1件: 97
487Adipose tissue harvest----1件: 51
488Adipose tissue-derived mesenchymal stem cells----1件: 97
489Adipose-cord mesenchymal stromal cells (A-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 97
490Adjunctive analgesics----1件: 70
491Adjunctive anti-depressants----1件: 70
492Adjuvant without active component----2件: 6, 17
493ADL58591件: ADL5859---1件: 46
494ADMINISTRATION----1件: 19
495Administration Kit----1件: 19
496Administration of a high dose of desipramine1件: Desipramine2件: D00812 ,
D07791 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156
497Administration of a low dose of desipramine1件: Desipramine2件: D00812 ,
D07791 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156
498Administration of an ACE-inhibitor or not----1件: 210
499Administration of Cimzia®1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
500Administration of drug (Interferon-gamma 1-b) subcutaneously----1件: 65
501Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil4件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		11件: D00407 ,
D00473 ,
D00751 ,
D00752 ,
D00979 ,
D05000 ,
D05001 ,
D05002 ,
D05094 ,
D05095 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 49
502Administration of methylprednisolone, paracetamol and dexchlorpheniramine3件: Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone		8件: D00217 ,
D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 ,
D07803 		4件: HRH1,
NR3C1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49
503Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab		7件: D00407 ,
D00751 ,
D00979 ,
D02994 ,
D05000 ,
D05001 ,
D05002 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51
504Administration of stable isotope-labelled leucine-1件: Leucine1件: D00030 --1件: 6
505Adoport----1件: 222
506Adrabetadex1件: Adrabetadex---1件: 19
507Adrenal cortical hormone----1件: 224
508Adrenalina----1件: 299
509Adrenergic receptor binder (ARB)----1件: 224
510Adrenocorticotrophic hormone ACTH1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222
511Adrenocorticotropic Hormone1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 13, 50, 84
512Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
513Adrenocorticotropic Hormone Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 50
514Adrenocorticotropin hormone----1件: 145
515ADS-001----1件: 231
516ADS-5102----2件: 6, 13
517ADS-5102 (extended release amantadine HCl)1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
518ADS-5102, 137 mg----1件: 13
519ADS-5102, 274 mg----1件: 13
520ADSVF----2件: 15, 96
521ADSVF application in the right hand----1件: 51
522Adult human mesenchymal stem cells1件: Remestemcel-L1件: D09719 --2件: 85, 96
523Advagraf 0,5mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
524Advagraf 1mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
525Advagraf 5mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
526Advagraf prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
527ADVATE1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
528ADVATE (rAHF - PFM)1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
529ADVATE (rAHF-PFM)1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
530ADVATE 1000 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
531ADVATE 1000IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
532ADVATE 500 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant1件: D02958 --1件: 288
533Adverse Reactions of Gammagard subcutaneously at Week 12----1件: 65
534Adverse Reactions of Gammagard subcutaneously at Week 24----1件: 65
535Adverse Reactions of Gammagard subcutaneously at Week 36----1件: 65
536Adverse Reactions of Gammagard subdermally at Week 12----1件: 65
537Adverse Reactions of Gammagard subdermally at Week 24----1件: 65
538Adverse Reactions of Gammagard subdermally at Week 36----1件: 65
539ADX-102 1% Topical Dermal Cream (reproxalap)1件: Reproxalap1件: D11309 --1件: 160
540ADX48621----1件: 6
541AEB071----1件: 97
542AEB071A----1件: 97
543AED----1件: 158
544AEGR-733----1件: 79
545AER-901 Solution for Nebulization----1件: 86
546AER002----1件: 299
547Aerolised Liposomal Ciclosporin A1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
548Aerolised Liposomal Ciclosporin A 10mg1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
549Aerolised Liposomal Ciclosporin A 5mg1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
550Aeroquin----1件: 299
551Aerosol interferon-gamma----1件: 85
552Aerosolized human Alpha-1 Antitrypsin----1件: 231
553Aerosolized iloprost1件: Iloprost1件: D02721 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
554Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299
555Aerosoltherapy----1件: 299
556AeroVanc----1件: 299
557AERT, (R)-Baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
558Aesculus Hippocastanum / Horse Chestnut1件: Horse chestnut1件: D12028 --1件: 210
559AEZS-130----1件: 78
560AEZS-130 (formerly ARD-07)----1件: 78
561AF056----1件: 206
562AF37702 Injection----1件: 283
563AF37702, Hematide1件: Peginesatide1件: D09946 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
564AFAMELANOTIDE1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬2件: 159, 254
565Afamelanotide (16 mg implant)1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 159
566Afamelanotide Implant1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254
567Afegostat1件: Afegostat1件: D09576 --1件: 19
568Afegostat tartrate1件: Afegostat1件: D09576 --1件: 19
569AFFITOPE® PD01A----1件: 6
570AFFITOPE® PD01A + Adjuvant----2件: 6, 17
571AFFITOPE® PD03A + Adjuvant----1件: 17
572Afinitor1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬3件: 34, 89, 158
573Afinitor (everolimus)1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 137
574Afinitor 5mg Tablets1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158
575Aflibercept1件: Aflibercept1件: D09574 3件: PGF,
VEGFA,
VEGFB 💬		24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬2件: 90, 166
576AFQ056----3件: 6, 8, 206
577AFQ056 with L-dopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
578AFQ065----1件: 6
579Afucosylated IgG1 kappa monoclonal antibody----1件: 300
580AG011----1件: 97
581AG011 - Capsules----1件: 97
582AG011 - Enema----1件: 97
583AG10----1件: 28
584AG10 HCl----1件: 28
585Agalsidase----1件: 19
586AGALSIDASE ALFA1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
587Agalsidase Alpha1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
588AGALSIDASE BETA1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
589Agalsidase beta (GZ419828)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
590Agalsidase beta (recombinant form)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
591AGALSIDASI ALFA----1件: 19
592AGALSIDASI BETA----1件: 19
593AGEE cream----1件: 13
594AGLE 102----1件: 36
595AGM 719----1件: 46
596AGN 203818----1件: 226
597Agomelatine1件: Agomelatine1件: D02578 3件: HTR2C,
MTNR1A,
MTNR1B 💬		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6
598Agomelatine or PIacebo1件: Agomelatine1件: D02578 3件: HTR2C,
MTNR1A,
MTNR1B 💬		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6
599Agri-King Synbiotic (AKSB)----1件: 96
600Agrippal S1 (Influenza vaccination)----1件: 46
601AGS-009----1件: 49
602AGT-181----1件: 19
603AGT-181 (HIRMAb-IDUA)----1件: 19
604AGT-182----1件: 19
605AGUA PARA PREPARACIONES INYECTABLES----1件: 78
606AHA----1件: 6
607AHA Exergame System----1件: 6
608AHSC----1件: 13
609AI-1000 G2----1件: 46
610AIDSVAX® B/E----1件: 49
611AIMSPRO----2件: 13, 51
612AIN----1件: 13
613AIN457----8件: 13, 37, 41, 46, 56, 96, 107, 271
614AIN457, 150 mg----1件: 271
615AIN457, 150mg----1件: 37
616AIN457, 75 mg----1件: 271
617AIN457A----1件: 271
618AIN457F----3件: 46, 107, 271
619Air----8件: 3, 13, 51, 58, 85, 97, 193, 299
620AIR DNase----1件: 299
621AIR DNase™----1件: 299
622Air filled balloon catheter----1件: 51
623Air stacking manuever----1件: 3
624AIR001----1件: 86
625AIR001 (sodium nitrite inhalation solution)1件: Nitrite---1件: 86
626AIR001 Inhalation Solution----1件: 86
627AIR001 Inhalation Solution (Expansion arm)----1件: 86
628Airway clearance technique----1件: 299
629AJG501----1件: 97
630AJG511----1件: 97
631AJM300----1件: 97
632Ajulemic acid1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
633AK002----1件: 98
634AK102----1件: 79
635AK106-0016161件: AK106-001616---1件: 46
636AK1320 MS----1件: 70
637AKBM-3031----1件: 49
638AKCEA-ANGPTL3-LRX----2件: 79, 265
639Aknemin----1件: 201
640Aknemin 50----1件: 201
641AKR-501, YM-477----1件: 63
642AKST4290----2件: 6, 162
643AL----10件: 5, 7, 13, 28, 51, 67, 86, 97, 114, 127
644AL-108----1件: 5
645AL001----2件: 2, 127
646AL01211----1件: 67
647AL2846 capsules----1件: 34
648ALA----1件: 286
649Alanine1件: Alanine1件: D00012 --5件: 6, 13, 251, 298, 299
650Albendazole1件: Albendazole1件: D00134 --1件: 96
651Albendazole (Eskazole)1件: Albendazole1件: D00134 --1件: 96
652Albumen1件: Egg white---1件: 96
653Albumin----3件: 2, 20, 51
654Albumin (Human) 20%, United States Pharmacopeia (USP)----1件: 231
655Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14
656Albumin solution----1件: 20
657ALBUMINE HUMAINE----1件: 96
658Albunorm® 5%,----1件: 20
659Albutein 5%----1件: 2
660Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 12, 13, 86, 89, 113, 231, 256, 299
661Albuterol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89
662Albuterol inhaler.1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 231, 299
663Albuterol nebulizer1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89
664Albuterol.1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
665Albutropin----1件: 78
666Albúmina humana----1件: 2
667Alcohol1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--4件: 13, 58, 279, 298
668Alcohol Septal Ablation1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--1件: 58
669Alcohol Wipes vs. No Alcohol Wipes1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--1件: 13
670ALD518----1件: 46
671ALD518 monoclonal antibody (anti IL-6 mAb)----1件: 46
672ALDESLEUCHINA----1件: 49
673ALDESLEUKIN1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬4件: 49, 65, 96, 97
674Aldosterone1件: Aldosterone1件: D10528 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬1件: 222
675Aldurazyme1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
676Aldurazyme (laronidase)1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬2件: 19, 256
677Aldurazyme (Recombinant Human Alpha-L-Iduronidase)1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
678ALDURAZYME*INFUS 1FL 5ML 500U1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
679Alefacept1件: Alefacept1件: D02800 1件: CD58 💬2件: Cell adhesion molecules, Epstein-Barr virus infection 💬6件: 37, 60, 65, 164, 284, 285
680ALEMTUZUMAB1件: Alemtuzumab1件: D02802 1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
681Alemtuzumab (already received by alemtuzumab cohort between 1991 and 19941件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 46
682Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 46
683Alemtuzumab (Campath )1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 60
684Alemtuzumab (Campath)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 15
685Alemtuzumab (GZ402673)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
686Alemtuzumab 0.2 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
687Alemtuzumab 0.3 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
688Alemtuzumab 12 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
689Alemtuzumab 24 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
690Alemtuzumab and Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 		2件: CD52,
MS4A1 💬		-1件: 60
691Alemtuzumab GZ4026731件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
692Alemtuzumab immunotherapy1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
693Alemtuzumab Injection1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
694Alemtuzumab Injection [Lemtrada]1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
695Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 		2件: CD52,
MS4A1 💬		-1件: 63
696Alendronat Teva----1件: 46
697Alendronate1件: Alendronic acid2件: D00939 ,
D07119 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 19, 41, 46, 50, 271, 274, 299
698Alendronate sodium1件: Alendronic acid2件: D00939 ,
D07119 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 19, 299
699Alendronate versus alfacalcidol (1-alpha OH vitamin D)3件: Alendronic acid,
Alfacalcidol,
Vitamin D		3件: D00939 ,
D01518 ,
D07119 		2件: FDPS,
VDR 💬		9件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬3件: 41, 46, 50
700ALENDRONIC ACID1件: Alendronic acid2件: D00939 ,
D07119 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 46, 274
701Alentuzumab (Campath)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 65
702Alequel----1件: 96
703Alfa-manosidadas humana recombinante----1件: 19
704Alfacalcidol1件: Alfacalcidol1件: D01518 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬8件: 41, 46, 49, 50, 96, 107, 235, 238
705Alfacalcidol 2 micrograms/ml1件: Alfacalcidol1件: D01518 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107
706Alfuzosin1件: Alfuzosin2件: D01692 ,
D07124 		1件: ADRA1A 💬7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13
707Alga Dunaliella Bardawil----1件: 90
708Alga Dunaliella Bardawil powder----1件: 90
709Alga Dunaliella Bardawill----1件: 90
710Algin1件: Alginic acid1件: D02324 --1件: 97
711Alginate1件: Alginic acid1件: D02324 --2件: 53, 299
712Alginate oligosaccharide1件: Alginic acid1件: D02324 --1件: 299
713Alginic acid1件: Alginic acid1件: D02324 --1件: 51
714ALGLUCOSIDASE ALFA1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
715Alglucosidase Alfa (Genetical Recombination)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
716Alglucosidase alfa (GZ419829)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
717ALGLUCOSIDASE ALFA (MYOZYME)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
718Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA])1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
719Alglucosidase alfa GZ4198291件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
720Alglucosidase alfa GZ419829 (Myozyme)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
721Alglucosidase alpha----1件: 256
722ALGLUCOSIDASI ALFA UMANA RICOMBINANTE----1件: 256
723Alicaforsen1件: Alicaforsen---2件: 96, 97
724Alicalm (polymeric liquid formula)----1件: 96
725ALIROCUMAB1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
726Alirocumab SAR236553 (REGN727)1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
727Aliskiren1件: Aliskiren1件: D03208 1件: REN 💬3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬3件: 66, 167, 222
728ALITRETINOIN1件: Alitretinoin1件: D02815 5件: RARA,
RARB,
RXRA,
RXRB,
RXRG 💬		19件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 49
729ALK-001----1件: 301
730ALK-001 (No generic name)----1件: 301
731Alkaline Phosphatase1件: Alkaline Phosphatase---4件: 46, 93, 97, 172
732Alkalinized Lidocaine-Heparin2件: Heparin,
Lidocaine		4件: D00358 ,
D02086 ,
D07510 ,
D08127 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226
733ALKERAN1件: Melphalan1件: D00369 --2件: 28, 60
734ALKS 8700----1件: 13
735ALKS 8700 Delayed Release (DR)1件: Manganese citrate---1件: 13
736ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13
737All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
738All subjects will receive maraviroc 300mg orally twice a day for 6 weeks1件: Maraviroc1件: D06670 1件: CCR5 💬9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 84
739All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine----1件: 2
740All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-----1件: 2
741All-trans retinoic acid1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 94
742All-Trans Retinoid Acid(ATRA)1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 63
743ALLANTOIN1件: Allantoin1件: D00121 --1件: 36
744ALLANTOINA----1件: 36
745Allergen----1件: 98
746Allergy immunotherapy (allergy shots)----1件: 98
747Allo BMT----1件: 65
748Allo-APZ2-EB----1件: 36
749ALLO-ASC----1件: 96
750ALLO-ASC-CD----1件: 96
751ALLO-ASC-DFU----1件: 36
752Allo-hMSCs----2件: 211, 299
753AlloGen-LI----1件: 70
754Allogeneic adipose tissue-derived mesenchymal stem cells----1件: 97
755ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED----2件: 36, 53
756Allogeneic adipose tissue-derived MSC----1件: 36
757Allogeneic adipose tissue-derived stromal/stem cells----1件: 53
758Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)1件: Remestemcel-L1件: D09719 --1件: 85
759Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)----1件: 96
760Allogeneic bone marrow transplant----1件: 49
761Allogeneic Bone Marrow Transplantation----9件: 60, 62, 65, 96, 164, 283, 284, 285, 286
762Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)----1件: 6
763Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)----1件: 6
764Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)----1件: 6
765Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)----1件: 6
766Allogeneic Cardiosphere-Derived Cells (CAP-1002)1件: CAP-1002---1件: 113
767Allogeneic donor derived B-lymphocytes----1件: 60
768Allogeneic fecal microbiota----1件: 13
769Allogeneic hematopoietic stem cell transplantation----8件: 28, 51, 60, 62, 65, 164, 284, 285
770Allogeneic HSC----1件: 65
771Allogeneic HSCT----1件: 65
772Allogeneic Human Cardiosphere-Derived Stem Cells----1件: 86
773Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----1件: 13
774ALLOGENEIC MESENCHYMAL PRECURSOR CELLS----1件: 46
775Allogeneic Mesenchymal Stem Cells----1件: 47
776Allogeneic Mesenchymal Stem Cells (AlloMSC)----2件: 51, 53
777Allogeneic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
778ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 49
779Allogeneic MSC (AlloMSC)----1件: 49
780ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED----1件: 90
781Allogeneic peripheral blood stem cell----1件: 65
782Allogeneic skin-derived ABCB5-positive mesenchymal stem cells----1件: 36
783Allogeneic Stem Cell Therapy----1件: 96
784Allogeneic Stem Cell Transplant----3件: 53, 56, 60
785Allogeneic stem cell transplantation----5件: 19, 20, 49, 62, 84
786Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation----1件: 17
787Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation----1件: 17
788Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601----1件: 96
789Allogenic eASCs 5 million cells/ml suspension for injection CX601----1件: 96
790Allogenic eASCs 5 million cells/ml suspension for injection. CX601----1件: 96
791Allogenic eASCs 5 million/ml suspension for injection.----1件: 96
792ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS----1件: 251
793Allogenic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
794Allogenic parathyroid cells----1件: 235
795Allogenic Stem Cell Transplantation----1件: 60
796Allograft----1件: 70
797Allopregnanolone1件: Brexanolone1件: D11149 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 205
798Allopurinol1件: Allopurinol1件: D00224 1件: XDH 💬5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬6件: 6, 46, 57, 66, 96, 97
799Allopurinol Sandoz 100 mg, tabletten1件: Allopurinol1件: D00224 1件: XDH 💬5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬1件: 96
800ALLOPURINOL SODIUM1件: Allopurinol1件: D00224 1件: XDH 💬5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬1件: 96
801AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226
802ALN-51547----1件: 28
803ALN-60212----1件: 79
804ALN-60519----1件: 254
805ALN-61444----1件: 231
806ALN-62643----2件: 62, 109
807ALN-65585----1件: 234
808ALN-77412----1件: 231
809ALN-AAT----1件: 231
810ALN-AAT02----1件: 231
811ALN-AS1----1件: 254
812ALN-CC5----4件: 11, 62, 66, 109
813ALN-GO1----1件: 234
814ALN-PCSSC1件: Inclisiran1件: D11931 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
815ALN-TTRSC----1件: 28
816AloASC----1件: 97
817Aloe1件: Aloe vera leaf---2件: 97, 226
818Aloe Barbadensis Miller1件: Aloe vera leaf---1件: 97
819Aloe vera1件: Aloe vera leaf---3件: 53, 97, 226
820Aloe vera gel1件: Aloe vera leaf---1件: 97
821Alofisel1件: Darvadstrocel1件: D11397 --1件: 96
822Alpha 1-Antitrypsin1件: Alpha-1-proteinase inhibitor---2件: 231, 298
823Alpha 1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231
824Alpha 1-proteinase inhibitor (human)1件: Alpha-1-proteinase inhibitor---1件: 231
825Alpha beta depletion----2件: 60, 284
826Alpha interferon----1件: 56
827Alpha Lipoic Acid1件: Lipoic acid2件: D00048 ,
D00086 		--1件: 13
828Alpha-1 Antitrypsin (AAT)----1件: 231
829Alpha-1 Antitrypsin (human)----1件: 231
830Alpha-1 HC 100 mg----1件: 299
831Alpha-1 HC 200 mg----1件: 299
832Alpha-1 MP----1件: 231
833Alpha-1 proteinase inhibitor (human)----1件: 231
834ALPHA-1-ANTITRYPSIN1件: Alpha-1-proteinase inhibitor---1件: 231
835Alpha-2C AR antagonist----1件: 51
836Alpha-galactosidase A1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
837Alpha-glucosidase1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
838ALPHA-LIPOIC ACID1件: Lipoic acid2件: D00048 ,
D00086 		--2件: 2, 13
839Alpha-lipoic acid and L-acetyl carnitine2件: Levocarnitine,
Lipoic acid		5件: D00048 ,
D00086 ,
D02030 ,
D02176 ,
D04713 		--1件: 5
840Alpha-tocopherol2件: Tocopherol,
Vitamin E		2件: D02331 ,
D02332 		--2件: 49, 206
841Alpha-tocotrienol quinone1件: Tocotrienol---2件: 21, 156
842Alpha-tocotrienolquinone----1件: 18
843Alpha1-antitrypsin----1件: 13
844Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299
845Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299
846Alphanate1件: Von Willebrand factor human---1件: 288
847Alphanate 1000 I.U.1件: Von Willebrand factor human---1件: 288
848Alphanate 1500 I.U.1件: Von Willebrand factor human---1件: 288
849Alphanate SD/HT1件: Von Willebrand factor human---1件: 288
850ALPHANATE*INF 1F 1000UI+F 10ML1件: Von Willebrand factor human---1件: 288
851ALPHANATE*INF 1F 1500UI+F 10ML1件: Von Willebrand factor human---1件: 288
852ALPHANATE*INF 1F 250UI+F 5ML1件: Von Willebrand factor human---1件: 288
853ALPHANATE*INF 1F 500UI+F 5ML1件: Von Willebrand factor human---1件: 288
854ALPN-101----1件: 49
855Alprazolam1件: Alprazolam1件: D00225 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 8, 75
856Alprostadil1件: Alprostadil2件: D00180 ,
D02705 		1件: PTGER1 💬4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬2件: 51, 70
857ALRN-5281 0.015 mg/kg----1件: 78
858ALRN-5281 0.05 mg/kg----1件: 78
859ALRN-5281 0.15 mg/kg----1件: 78
860Also referred to as 'MEDI2070'----2件: 96, 97
861Also referred to as MED2070----1件: 96
862Also referred to as MEDI2070----2件: 96, 97
863Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation----1件: 6
864Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation----1件: 6
865Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation----1件: 6
866Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation----1件: 6
867Alternative osteoporosis medications----1件: 274
868ALTH12-1:4----1件: 97
869ALTH12-2:4----1件: 97
870ALTRI FARMACI DEL SISTEMA NERVOSO----1件: 13
871Altropane1件: Altropane---1件: 6
872ALTROPANE®1件: Altropane---1件: 6
873ALTU-1351件: ALTU-135---1件: 299
874ALTU-238----1件: 78
875ALTUS-135----1件: 299
876Aluminium1件: Aluminium---2件: 11, 46
877Aluminium hydroxide3件: Aluminium,
Aluminum hydroxide,
Hydroxide ion		1件: D02416 --2件: 11, 46
878Aluminium phosphate3件: Aluminium,
Aluminium phosphate,
Phosphate ion		---1件: 46
879Aluminum1件: Aluminium---1件: 11
880Aluminum hydroxide3件: Aluminium,
Aluminum hydroxide,
Hydroxide ion		1件: D02416 --1件: 11
881Alvarez 2----1件: 37
882ALVELESTAT1件: Alvelestat---1件: 231
883Alvelestat (MPH966)1件: Alvelestat---1件: 231
884Alvelestat oral tablet - dose 11件: Alvelestat---1件: 231
885Alvelestat oral tablet - dose 21件: Alvelestat---1件: 231
886Alvelestat tosylate1件: Alvelestat---1件: 231
887Alwextin cream----1件: 36
888ALX-0061----2件: 46, 49
889ALX-0061 150 mg/mL----1件: 49
890ALX-0061 Nanobody----1件: 46
891ALX-0081----1件: 64
892ALX-009----1件: 299
893ALX-0600----1件: 96
894ALXN1102----1件: 62
895ALXN1103----1件: 62
896ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109
897ALXN1830----3件: 11, 35, 61
898ALXN1840----1件: 171
899ALXN1850----1件: 172
900ALXN2040----1件: 62
901ALXN2040 (ACH-0144471)----1件: 62
902ALXN2050----2件: 11, 62
903ALZT-OP1a (cromolyn)1件: Cromoglicic acid2件: D00526 ,
D07753 		--1件: 2
904AM-01----1件: 51
905Amantadin-ratiopharm 100mg----1件: 6
906AMANTADINE1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127
907Amantadine 300 mg1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
908Amantadine HCl ER1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
909Amantadine HCl Extended Release1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
910Amantadine HCl Extended Release Capsule1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
911AMANTADINE HYDROCHLORIDE1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
912Amantadine hydrochloride (HCl)1件: Amantadine2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
913Amantadine sulfate2件: Amantadine,
Sulfate ion		2件: D00777 ,
D07441 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
914Ambirix----1件: 107
915Ambrisentan1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 51, 84, 85, 86, 88, 210, 211
916Ambrisentan - high dose1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
917Ambrisentan - low dose1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
918Ambrisentan 5 mg1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88
919Ambrisentan 5 mg film-coated tablets1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
920Ambrisentan 5mg film-coated tablets [marketed product]1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
921Ambrisentan plus Spironolactone2件: Ambrisentan,
Spironolactone		2件: D00443 ,
D07077 		2件: EDNRA,
NR3C2 💬		8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
922Ambrisentan Tablet1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
923AMBROSAN 60mg Tablets----1件: 6
924Ambroxol1件: Ambroxol1件: D07442 --2件: 6, 19
925Ambroxol Hydrochloride1件: Ambroxol1件: D07442 --1件: 6
926AmCell CliniMACs----1件: 285
927AMD3100----1件: 285
928American Ginseng2件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
929American ginseng extract HT-10012件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
930AMG 1081件: AMG 108---1件: 46
931AMG 139----1件: 96
932AMG 145----1件: 79
933AMG 162----2件: 46, 274
934AMG 181----2件: 96, 97
935AMG 357----1件: 46
936AMG 407----1件: 56
937AMG 531----1件: 63
938AMG 557----1件: 49
939AMG 557/MEDI5872----1件: 53
940AMG 570----2件: 46, 49
941AMG 592----3件: 46, 49, 97
942AMG 623----1件: 49
943AMG 714----1件: 46
944AMG 719----1件: 46
945AMG 785----1件: 274
946AMG 811----1件: 49
947AMG 827----2件: 46, 96
948AMG 827 140 mg----1件: 46
949AMG 827 210 mg----2件: 46, 96
950AMG 827 350 MG----1件: 96
951AMG 827 70 mg----1件: 46
952AMG 827 700 MG----1件: 96
953AMG-407----2件: 56, 107
954AMG145----1件: 79
955AMG181----1件: 97
956AMG407----2件: 56, 107
957AMG531----2件: 60, 63
958AMG592----2件: 46, 49
959AMG811----1件: 49
960Amgevita1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
961AMGEVITA (Adalimumab biosimilar )1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
962Amgevita 40 mg Injektionslösung im Fertigpen1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
963Amgevita 40 mg Injektionslösung in einer Fertigspritze1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
964Amgevita 40Mg Solution for Injection----2件: 96, 97
965AMGEVITA®1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
966AMIAS----1件: 67
967AMIFAMPRIDINA----2件: 3, 11
968Amifampridina fosfato----2件: 3, 11
969Amifampridine1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12
970Amifampridine Phosphate2件: Amifampridine,
Phosphate ion		1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12
971Amifampridine Phosphate 10 MG Oral Tablet2件: Amifampridine,
Phosphate ion		1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 3
972Amifostine1件: Amifostine1件: D00226 --1件: 28
973Amifostine trihydrate1件: Amifostine1件: D00226 --1件: 28
974AMIKACIN1件: Amikacin2件: D00865 ,
D02543 		--2件: 60, 299
975Amikacin nebulization1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
976AMIKACIN SULFATE2件: Amikacin,
Sulfate ion		2件: D00865 ,
D02543 		--1件: 299
977Amikacina1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
978Amikacina liposomal (Arikace?)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
979Amikacine1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
980Amikacine nebulization1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
981Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
982Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
983AMILASA----1件: 299
984Amiloride1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
985Amiloride HCl1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
986Amiloride Hydrochloride1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
987AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
988Amiloride Solution for Inhalation1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
989Amilostad----1件: 13
990Amilostad HCT----1件: 13
991Amilostad HCT tablets----1件: 13
992Amino acids1件: Amino acids---3件: 70, 240, 298
993Aminocaproic acid1件: Aminocaproic acid1件: D00160 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 70
994Aminohippurate1件: Aminohippuric acid2件: D01421 ,
D06890 		--1件: 67
995Aminohippurate Sodium Inj 20%1件: Aminohippuric acid2件: D01421 ,
D06890 		--1件: 67
996Aminolevulinic acid1件: Aminolevulinic acid2件: D02908 ,
D07567 		--4件: 34, 96, 254, 286
997Aminophylline1件: Aminophylline2件: D00227 ,
D05429 		18件: ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 63
998Aminopterin1件: Aminopterin---1件: 46
999AMINOSALICYLIC ACID1件: Aminosalicylic acid1件: D00162 --2件: 96, 97
1000Amiodarone1件: Amiodarone2件: D00636 ,
D02910 		16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 28, 127
1001Amiselimod----1件: 97
1002Amitriptylin1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1003Amitriptylin-CT1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1004Amitriptylin-ct Tabletten1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1005Amitriptyline1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 78, 97, 226, 299
1006Amitriptyline hydrochloride1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 97
1007Amitriptyline, fluoxetine and tramadol alone (control group)3件: Amitriptyline,
Fluoxetine,
Tramadol		6件: D00326 ,
D00809 ,
D00823 ,
D01355 ,
D07448 ,
D08623 		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78
1008Amivita----1件: 2
1009Amlodipine1件: Amlodipine3件: D00615 ,
D02914 ,
D07450 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 67, 298
1010Amlodipine (drug)1件: Amlodipine3件: D00615 ,
D02914 ,
D07450 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
1011Amlodipine Gel1件: Amlodipine3件: D00615 ,
D02914 ,
D07450 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
1012Ammonia1件: Ammonia1件: D02916 --3件: 86, 88, 296
1013Ammonium (15N) chloride1件: Chloride ion---1件: 251
1014Ammonium chloride2件: Ammonium chloride,
Chloride ion		1件: D01139 --3件: 96, 107, 251
1015AMN107----2件: 34, 86
1016Amniotic Epithelial Cells1件: Amniotic Epithelial Cells---1件: 26
1017Amniotic Fluid Allograft----1件: 70
1018Amorphous calcium carbonate2件: Calcium,
Carbonate ion		---1件: 235
1019Amoxapine1件: Amoxapine1件: D00228 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46
1020Amoxapine & dipyridamole2件: Amoxapine,
Dipyridamole		2件: D00228 ,
D00302 		4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬		8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
1021Amoxicilina1件: Amoxicillin3件: D00229 ,
D02925 ,
D07452 		--1件: 46
1022Amoxicillin1件: Amoxicillin3件: D00229 ,
D02925 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
1023Amoxicillin and Clavulanic acid1件: Clavulanic acid1件: D07711 --1件: 299
1024Amoxicillin and doxycyclin2件: Amoxicillin,
Doxycycline		8件: D00229 ,
D00307 ,
D02129 ,
D02925 ,
D03903 ,
D03904 ,
D07452 ,
D07876 		--1件: 97
1025Amoxicillin hydrate1件: Amoxicillin3件: D00229 ,
D02925 ,
D07452 		--1件: 63
1026Amoxicillin, metronidazole and doxycycline3件: Amoxicillin,
Doxycycline,
Metronidazole		11件: D00229 ,
D00307 ,
D00409 ,
D02129 ,
D02925 ,
D03903 ,
D03904 ,
D05016 ,
D05017 ,
D07452 ,
D07876 		--1件: 97
1027Amoxycillin1件: Amoxicillin3件: D00229 ,
D02925 ,
D07452 		--1件: 63
1028AMP----1件: 46
1029AMP-110----1件: 46
1030Ampalex----1件: 206
1031AMPC1件: Cyclic adenosine monophosphate---1件: 84
1032Amphotericin----1件: 299
1033Amphotericin B1件: Amphotericin B1件: D00203 --1件: 299
1034AMPHOTERICINE B, LIPOSOME----1件: 60
1035Ampreloxetine1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1036Ampreloxetine chydrochloride1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1037Ampreloxetine hydrochloride1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1038Amprenavir1件: Amprenavir1件: D00894 --1件: 265
1039Ampyra1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 6, 13
1040Ampyra first,1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 6
1041AMSC----1件: 2
1042AMT----4件: 8, 46, 97, 321
1043AMT-101----2件: 46, 97
1044AMT-101 (oral)----1件: 97
1045AMT-130----1件: 8
1046AMX0035----1件: 2
1047Amyl Nitrite2件: Amyl Nitrite,
Nitrite		1件: D00517 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58
1048Amyl nitrite inhalation2件: Amyl Nitrite,
Nitrite		1件: D00517 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58
1049AMYLASE----1件: 299
1050Amyvid1件: Florbetapir (18F)---2件: 13, 127
1051Amyvid radiopharmaceutical1件: Florbetapir (18F)---1件: 13
1052AMZ002----1件: 145
1053AN100226----2件: 13, 96
1054AN100226, BG00002----1件: 13
1055ANA001XHCl (Syntagon) or VEXA-04 (Patheon)----1件: 156
1056ANACETRAPIB1件: Anacetrapib1件: D08855 1件: CETP 💬1件: Cholesterol metabolism 💬1件: 79
1057Anaerobically Cultivated Human Intestinal Microbiota----1件: 51
1058Anaerobically Cultivated medium----1件: 51
1059Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬17件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
1060Anakinra (Kineret®)1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46
1061Anakinra (r-metHuIL-1ra)1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46
1062Anakinra / kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107
1063Anakinra and PEG sTNF-R12件: Anakinra,
Pegsunercept		2件: D02934 ,
D05393 		3件: IL1R1,
IL1R2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
1064Analgesics----1件: 298
1065Analysis of gamma globulin----1件: 84
1066ANASTROZOLE1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬3件: 78, 86, 193
1067Anatomical Landmark-guided Suprascapular Nerve Block----1件: 149
1068ANAVEX2-73----2件: 6, 156
1069ANAVEX2-73 (blarcamesine)1件: Blarcamesine1件: D11383 6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 156
1070ANAVEX2-73 oral liquid----1件: 156
1071ANB019----1件: 37
1072AND (Andrographolide)1件: Andrographolide---1件: 97
1073Andecaliximab----4件: 46, 96, 97, 299
1074AndoSan----2件: 96, 97
1075AndroGel 1 % Topical Gel----1件: 13
1076Androgel 10 grams of gel containing 100 mg of testosterone1件: Testosterone6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13
1077Androgens----1件: 60
1078ANDROGRAPHIS PANICULATA----1件: 97
1079ANDROGRAPHIS PANICULATA (ethanol extract)1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--1件: 97
1080Andrographolide1件: Andrographolide---1件: 97
1081Andrographolides----1件: 13
1082Anesthetic Topical Adhesive Synera----1件: 13
1083Anfibatide1件: Anfibatide---1件: 64
1084Angiotensin1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬7件: 17, 19, 46, 66, 86, 222, 224
1085Angiotensin blockade1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66
1086Angiotensin II1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222
1087Angiotensin receptor blockers1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 46
1088Angiotensin-(1-7)1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17
1089Angiotensin-converting enzyme (ACE) inhibitor1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224
1090Angiotensin-converting enzyme inhibitor(ACEI)1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224
1091Anhydrous Amiloride Hydrochloride1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225
1092ANHYDROUS CARBIDOPA1件: Carbidopa1件: D00558 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1093ANIFROLUMAB1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 46, 49
1094Anifrolumab (MEDI-546)1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 46
1095Anifrolumab 1000 mg1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49
1096Anifrolumab 300 mg1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49
1097Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46
1098ANK-700----1件: 13
1099Anle138b1件: anle138b---1件: 6
1100Anrukinzumab1件: Anrukinzumab1件: D08857 1件: IL13 💬8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 97
1101Anti BAFF (B cell activating factor)----1件: 49
1102Anti Beta7----1件: 97
1103Anti CD3 monoclonal antibody----1件: 97
1104Anti human granulocyte-macrophage colo----1件: 46
1105Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL----1件: 46
1106Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody----1件: 46
1107Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46
1108Anti IL 6 mAb----1件: 46
1109Anti IL-1beta antibody----1件: 46
1110Anti IL-1beta antibody, subclass IgG4----1件: 46
1111Anti IL-1ß antibody----1件: 46
1112Anti IL-1ß antibody, subclass IgG4----1件: 46
1113Anti LP40 antibody, subclass IgG4----1件: 49
1114Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46
1115Anti LP40 anticuerpo, subclase IgG4----1件: 49
1116Anti Lymphotoxin Alpha----1件: 46
1117Anti TNF----1件: 96
1118Anti TNF + Meth----1件: 46
1119Anti TNF Alfa.----1件: 96
1120Anti TNF alpha agent----1件: 271
1121Anti TNF alpha therapy----1件: 271
1122Anti TNF humanized antibody Fab fragment-PEG conjugate----1件: 96
1123Anti TNF therapy including infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1124Anti-(complement C5a) IgG4 chimeric monoclonal antibody----1件: 269
1125Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain)----1件: 271
1126Anti-BAFFR antibody----1件: 95
1127Anti-Beta Interferon (PF-06823859)----1件: 50
1128Anti-blood dendritic cell antigen 2----1件: 49
1129Anti-C5 antibody----4件: 11, 14, 62, 109
1130Anti-C5aR----1件: 46
1131Anti-CD19-CAR-T cells----1件: 49
1132Anti-CD20 B cell depletion with Truxima1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49
1133Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46
1134Anti-CD25 Humanized Monoclonal Antibody----1件: 13
1135Anti-CD28dAb----3件: 49, 53, 160
1136Anti-CD31件: Muromonab1件: D05092 3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 96, 97
1137Anti-CD3 Monoclonal antibody1件: Muromonab1件: D05092 3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 96, 97
1138Anti-CD40L1件: Toralizumab1件: D06193 1件: CD40LG 💬14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬1件: 63
1139Anti-CD40LdAb----1件: 63
1140Anti-CD45----3件: 60, 65, 285
1141Anti-CD52 monoclonal antibody----1件: 13
1142Anti-CT51 antigen mAb----1件: 51
1143Anti-D----1件: 63
1144Anti-GM-CSF receptor alpha----1件: 46
1145Anti-human immunoglobulin, equine----1件: 60
1146Anti-Human Interleukin-23 Monoclonal Antibody----1件: 271
1147Anti-human T-lymphocyte immunoglobulin from horse----1件: 60
1148ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS----1件: 51
1149Anti-hypertensive medications----1件: 67
1150Anti-IL-12----2件: 13, 96
1151Anti-IL-201件: Fletikumab1件: D11756 1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
1152Anti-IL-20 (109-0012)1件: Fletikumab1件: D11756 1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
1153Anti-IL-23 monoclonal antibody----1件: 96
1154Anti-IL-36R monoclonal antibody----1件: 37
1155Anti-IL-6 mAb----2件: 46, 96
1156Anti-inflammatory drugs----1件: 46
1157Anti-integrin alphaV mAb----1件: 51
1158Anti-Interferon-gamma monoclonal antibody----1件: 96
1159Anti-interleukin-1B monoclonal antibody----1件: 106
1160Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----2件: 96, 97
1161Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----2件: 96, 97
1162Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----2件: 96, 97
1163Anti-Interleukin-6 Monoclonal----1件: 46
1164Anti-Interleukin-6 Monoclonal Antibody----2件: 46, 96
1165Anti-IP-10 Antibody----1件: 97
1166Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody----1件: 49
1167Anti-MAdCAM antibody----2件: 96, 97
1168Anti-myostati----1件: 113
1169Anti-Myostatin Adnectin----1件: 113
1170Anti-pandemic H1N1 influenza vaccine----6件: 46, 49, 50, 51, 53, 107
1171Anti-Parkinson medication----5件: 5, 6, 7, 8, 17
1172Anti-Parkinsonian Drugs----1件: 6
1173Anti-pseudomonas IgY gargle----1件: 299
1174Anti-reflux pharmacotherapy----1件: 299
1175ANTI-SCLEROSTIN MONOCLONAL ANTIBODY----1件: 274
1176Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
1177Anti-thymocyte globulin (ATG)----1件: 164
1178Anti-thymocyte globulin (horse)----1件: 60
1179Anti-Thymocyte Globulin (Rabbit)1件: Rabbit---4件: 60, 65, 96, 285
1180Anti-Thymocyte Globulin, Rabbit2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 51
1181Anti-TL1A----1件: 97
1182Anti-TNF----4件: 46, 96, 107, 271
1183Anti-TNF agents----1件: 271
1184Anti-TNF biologics----2件: 46, 271
1185Anti-TNF Biologics Therapy----1件: 46
1186Anti-TNF discontinuation: Physiological saline solution----2件: 96, 97
1187Anti-TNF Drug----2件: 96, 97
1188Anti-TNF humanized antibody Fab fragment - PEG conjugate----1件: 46
1189Anti-TNF humanized antibody Fab' fragment - PEG conjugate----1件: 46
1190Anti-TNF suspended perioperatively----1件: 46
1191Anti-TNF therapy----3件: 46, 96, 97
1192Anti-TNF therapy (etanercept or adalimumab)2件: Adalimumab,
Etanercept		2件: D00742 ,
D02597 		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271
1193Anti-TNF-alpha----1件: 46
1194Anti-TNF: Infliximab (Infusion)1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1195Anti-TNF:Adalimumab (Subcutaneus)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1196Anti-TNFa continued perioperatively----1件: 46
1197Anti-Tumor Necrosing Factor (TNF) Therapy----1件: 46
1198Anti-Tumor Necrosis Factor----1件: 271
1199Anti-Tumor Necrosis Factor Alpha Drug (Product)----1件: 46
1200Anti-tumor necrosis factor alpha monoclonal antibody----1件: 107
1201Anti-von Willebrand Factor Nanobody1件: Von Willebrand factor human---1件: 64
1202Anti-von Willebrand Factor Nanobody, Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: D11160 1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64
1203Anti-von Willebrand Factor Nanobody, INN = Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: D11160 1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64
1204Antiarrhythmic drugs----1件: 58
1205Antibiotic----1件: 299
1206Antibiotic cocktail----1件: 97
1207Antibiotic Regimen----1件: 84
1208Antibiotics----1件: 96
1209Anticholinergic medication----1件: 13
1210Anticorpo monoclonale anti GM-CSF umano----1件: 46
1211Anticorpo monoclonale anti IL-23----1件: 96
1212Anticorpo monoclonale anti-IL-23----1件: 96
1213Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2)----1件: 96
1214Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R.----1件: 46
1215Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13
1216Antiepileptic drug (1 to 3 only)----1件: 158
1217Antigen-specific T cells CART/CTL and DCvac----1件: 34
1218Antihemophilic Factor (Recombinant)----1件: 288
1219Antihistamine----2件: 13, 46
1220Antihistamine (cetirizine or equivalent)1件: Cetirizine2件: D00664 ,
D07662 		1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 35
1221Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal----1件: 46
1222Antihypertensive drugs----1件: 67
1223Antilymphocyte serum----1件: 60
1224Antimicrobial therapy: Co-trimoxazole or Doxycycline1件: Doxycycline5件: D00307 ,
D02129 ,
D03903 ,
D03904 ,
D07876 		--1件: 85
1225Antimycotic----1件: 13
1226Antioxidant Cocktail----1件: 299
1227Antioxidant plus Pregabalin1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 298
1228Antioxidants----3件: 90, 298, 310
1229Antiparkinsonian Agent(s)----1件: 6
1230Antiplatelets----1件: 124
1231Antipyretic----1件: 257
1232Antiretroviral/Anti HIV----1件: 265
1233Antisense oligonucleotide----1件: 5
1234Antistaminici H1 - H2----1件: 299
1235Antithymocyte----1件: 13
1236Antithymocyte Globulin----3件: 60, 65, 284
1237Antithymocyte Globulin (ATG)----1件: 60
1238Antithymocyte globulin (Rabbit)1件: Rabbit---1件: 60
1239ANTITHYMOCYTE IMMUNOGLOBULIN1件: Antithymocyte immunoglobulin (rabbit)---2件: 13, 96
1240Antithymocyte immunoglobulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96
1241Antituberculous therapy along with steroids----1件: 84
1242Antiviral therapy----2件: 28, 60
1243Antivirale ad uso diretto----1件: 107
1244ANTOX----1件: 298
1245ANTOX (vers) 1.2----1件: 298
1246ANTOX (vers.)1.2----1件: 298
1247Antox version 1.2----1件: 298
1248ANX005----3件: 2, 8, 61
1249Anxiety/depression and work and activities----1件: 13
1250Any other approved Antiepileptic Drug----1件: 144
1251AOC 1001----1件: 113
1252AODG (Apigenin-7-O-glucuronide)1件: Apigenin---1件: 97
1253AP----4件: 2, 6, 13, 299
1254AP-101----1件: 2
1255AP-CD/LD----1件: 6
1256AP-PA02----1件: 299
1257AP01----1件: 85
1258AP09004----1件: 6
1259AP1189----2件: 46, 222
1260AP1903----3件: 60, 285, 326
1261AP1903 A594----3件: 60, 285, 326
1262Apabetalone1件: Apabetalone1件: D11131 4件: BRD2,
BRD3,
BRD4,
BRDT 💬		-1件: 86
1263Apadamtase alfa1件: Apadamtase alfa---1件: 64
1264Apademtase alfa----1件: 64
1265APCC, aPCC + TXA----1件: 288
1266APD334----5件: 93, 96, 97, 98, 269
1267APD334 L-arginine1件: Arginine1件: D02982 --1件: 97
1268APD371----1件: 96
1269APD421----1件: 107
1270APD811----1件: 86
1271Apelin----1件: 86
1272Apheresis----1件: 60
1273Apheresis catheter placement----1件: 96
1274API----2件: 231, 299
1275API-AAT----1件: 231
1276API-AAT, AD00370, ARC-AAT, API drug Substance----1件: 231
1277Apigenin1件: Apigenin---1件: 97
1278Apitegromab1件: Apitegromab1件: D11797 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 3
1279Apitox - pure honeybee toxin----1件: 13
1280Apixaban1件: Apixaban1件: D03213 1件: F10 💬1件: Complement and coagulation cascades 💬3件: 96, 97, 222
1281Apixaban 2.5 milligram1件: Apixaban1件: D03213 1件: F10 💬1件: Complement and coagulation cascades 💬2件: 96, 97
1282Apixaban 5 MG1件: Apixaban1件: D03213 1件: F10 💬1件: Complement and coagulation cascades 💬1件: 222
1283APL-130277----1件: 6
1284APL-2----5件: 2, 61, 62, 66, 222
1285APLA12----1件: 46
1286Aplindore1件: Aplindore---1件: 6
1287Aplindore MR tablets1件: Aplindore---1件: 6
1288APO-go----1件: 6
1289APO-go®----1件: 6
1290APO-P001----1件: 2
1291APOKINON----1件: 6
1292APOKYN1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1293Apomor----1件: 6
1294Apomorfina1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1295APOMORFINA CLORIDRATO1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1296Apomorp----1件: 6
1297Apomorphine1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7
1298Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1299Apomorphine HCl injection1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1300APOMORPHINE HYDROCHLORIDE1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1301Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1302Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1303Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1304Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1305APOMORPHINE HYDROCHLORIDE HEMIHYDRATE1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1306Apomorphine Hydrocloride1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1307Apomorphine Hydrocloride Hemihydrate1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1308Apomorphine infusion1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1309Apomorphine Injectable Solution1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1310Apomorphine Nasal Powder1件: Apomorphine2件: D02004 ,
D07460 		2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1311APORON----1件: 6
1312ApoTamox 10mg----1件: 111
1313Apple1件: Apple---1件: 70
1314Apple Watch and App1件: Apple---1件: 70
1315Application of Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
1316Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side1件: Sinecatechins1件: D08997 --1件: 160
1317Apraclonidine1件: Apraclonidine2件: D01008 ,
D07461 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11
1318Apraclonidine Hcl 0.5% Oph Soln1件: Apraclonidine2件: D01008 ,
D07461 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11
1319Apratastat1件: Apratastat1件: D08859 2件: ADAM17,
MMP13 💬		7件: Alzheimer disease, Coronavirus disease - COVID-19, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway 💬1件: 46
1320Apremilast1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬7件: 46, 50, 56, 97, 107, 162, 271
1321Apremilast (CC-10004)1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 56
1322Apremilast 10 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107
1323Apremilast 20 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107
1324Apremilast 30 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107
1325Apremilast 30mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 50
1326Apremilast tablet 20 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271
1327Apremilast tablet 30 mg BID1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271
1328APRINOX----1件: 67
1329Apriso 0.375G ER CAP----1件: 97
1330APRISO 375 mg extended-release capsules1件: Manganese citrate---1件: 97
1331AProArt----1件: 65
1332Aprotinin1件: Aprotinin1件: D02971 --1件: 28
1333Aprovel1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167
1334Aprovel (150 mg)1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222
1335Aprovel 150 mg Tablets1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222
1336APT-1011----1件: 98
1337APT-1011 - 3 mg----1件: 98
1338APVO210----1件: 97
1339AquADEK----1件: 299
1340AquADEKs-2----1件: 299
1341Aquamin----1件: 97
1342Aquamin®----1件: 97
1343AQW051----1件: 6
1344AQX-11251件: AQX-1125---1件: 226
1345AQX-1125 100 mg1件: AQX-1125---1件: 226
1346AQX-1125 200 mg1件: AQX-1125---1件: 226
1347AR-421件: AR-42---1件: 34
1348AR392830----1件: 86
1349AR401959 L-arginine1件: Arginine1件: D02982 --3件: 96, 97, 98
1350ARA 290----1件: 84
1351ARA290----1件: 46
1352Aramchol1件: Aramchol---1件: 265
1353ARAVA1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬3件: 46, 53, 162
1354Arava 20 mg filmdrasjerte tabletter----1件: 46
1355Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46
1356ARAVA®1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46
1357ARB----1件: 66
1358Arbaclofen1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬2件: 13, 206
1359Arbaclofen ER Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1360Arbaclofen Extended Release Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1361Arbaclofen Placarbil2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1362Arbaclofen placarbil 15 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1363Arbaclofen placarbil 30 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1364Arbaclofen placarbil 45 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1365ARC 1779----2件: 64, 288
1366ARC-AAT----1件: 231
1367ARC-AAT Injection----1件: 231
1368ARC1779----2件: 64, 288
1369ARC1779 Injection----2件: 64, 288
1370ARC1905----1件: 301
1371ARC1905 20 MG/ML----1件: 301
1372ARCOXIA----2件: 46, 271
1373ARCOXIA 90 mg comprimidos recubiertos con película----1件: 271
1374ARCT-810----1件: 251
1375ARD-101----1件: 193
1376ARD-3150----1件: 299
1377Arg----1件: 78
1378Arginin----1件: 78
1379Arginina1件: Arginine1件: D02982 --2件: 58, 78
1380ARGININA CLORIDRATO1件: Arginine1件: D02982 --1件: 78
1381Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
1382Arginine and Clonidine Stimulation Testing2件: Arginine,
Clonidine		3件: D00281 ,
D00604 ,
D02982 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 78
1383ARGININE HYDROCHLORIDE1件: Arginine1件: D02982 --1件: 78
1384Arginine stimulation test after each limb1件: Arginine1件: D02982 --1件: 78
1385Argininhydrochlorid----1件: 65
1386ARGX-113----4件: 11, 14, 35, 63
1387ARGX-117----1件: 14
1388ARGX-117 IV----1件: 14
1389ARICEPT1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 6, 13, 78, 124
1390Aricept 10 mg1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1391Aricept 10 mg filmdragerade tabletter1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1392Aricept 5 mg1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1393Aricept 5 mg filmdragerade tabletter1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1394Aricept 5 mg-Filmtabletten----1件: 6
1395ARICEPT 5*28 CPR 5 MG1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 124
1396Aricept 5mg-Filmtabletten----1件: 6
1397Aridol1件: Mannitol1件: D00062 --1件: 299
1398Aridol or Osmohale1件: Mannitol1件: D00062 --1件: 299
1399ARIKACE™----1件: 299
1400Arikayce1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1401Arikayce™1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1402Arikayce™ 140 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1403Arikayce™ 560 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1404Arikayce™ 70 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1405Arimidex1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬1件: 78
1406Arimidex (Anastrozole)1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬1件: 78
1407ARIMOCLOMOL1件: Arimoclomol1件: D11374 --3件: 2, 15, 19
1408Arimoclomol (hard gelatine capsule)2件: Arimoclomol,
Gelatin		3件: D00115 ,
D06892 ,
D11374 		--1件: 19
1409Arimoclomol (HPMC capsule)1件: Arimoclomol1件: D11374 --1件: 19
1410Arimoclomol citrate1件: Arimoclomol1件: D11374 --2件: 15, 19
1411Aripiprazole1件: Aripiprazole1件: D01164 4件: DRD2,
DRD3,
HTR1A,
HTR2A 💬		12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬2件: 6, 206
1412Arm 1 - GEH120714 (18F) Injection----1件: 13
1413Arm B: Rituxan®/Mabthera®1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
1414Armodafinil1件: Armodafinil1件: D03215 1件: SLC6A3 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84
1415ARN-6039----1件: 13
1416ARO-AAT----1件: 231
1417ARO-AAT Injection----1件: 231
1418ARO-C3----2件: 62, 66
1419ARO-ENaC----1件: 299
1420ARRY-371797----1件: 271
1421ARRY-371797, p38 inhibitor----2件: 46, 271
1422ARRY-438162----1件: 46
1423ARRY-438162, MEK inhibitor----1件: 46
1424ART-123----1件: 85
1425ART621----1件: 46
1426Artamin 150 mg----1件: 171
1427Artamin 250 mg----1件: 171
1428Artane----1件: 6
1429Artesunate1件: Artesunate1件: D02482 --3件: 18, 66, 96
1430Artesunate Oral Product1件: Artesunate1件: D02482 --1件: 18
1431Arthroscopic synovectomy of the wrist----1件: 46
1432Arthroscopic synovial tissue biopsy----1件: 46
1433Arthroscopy & saline irrigation alone----1件: 46
1434Artificial Saliva----1件: 53
1435Artilog----1件: 46
1436Arundic Acid1件: Arundic acid1件: D06296 --1件: 2
1437ARX2011件: ARX201---1件: 78
1438Arylsulfatase A----1件: 19
1439Arzerra1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1440ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1441ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1442Arzerra®1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1443AS----6件: 46, 53, 96, 97, 215, 271
1444AS Domelock System----1件: 46
1445AS INN----1件: 97
1446AS2----1件: 6
1447ASA----4件: 13, 96, 97, 251
1448ASACOL----1件: 97
1449Asacol (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1450Asacol (mesalamine) Delayed-release Tablets1件: Mesalazine1件: D00377 --1件: 97
1451Asacol 400 mg----1件: 97
1452Asacol 400 mg (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1453Asacol 400 mg tablet1件: Mesalazine1件: D00377 --1件: 97
1454Asacol 400mg tablet1件: Mesalazine1件: D00377 --1件: 97
1455Asacol 800 mg (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1456Asacol 800 mg tablet1件: Mesalazine1件: D00377 --1件: 97
1457Asacol 800mg tablet1件: Mesalazine1件: D00377 --1件: 97
1458Asacol Delayed Release Tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
1459Asacol Delayed-Release Tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
1460Asacol tablet1件: Mesalazine1件: D00377 --1件: 97
1461Asacol®1件: Mesalazine1件: D00377 --1件: 97
1462Asacol® 400 mg----1件: 97
1463ASASANTIN Retard----1件: 51
1464Asasantin Retard ®----1件: 51
1465ASB-683699----1件: 13
1466ASC----4件: 36, 51, 96, 97
1467ASC42 10 mg----1件: 93
1468ASC42 15 mg----1件: 93
1469ASC42 5 mg----1件: 93
1470Ascal(r) / carbasalate calcium2件: Calcium,
Carbaspirin calcium		1件: D03385 --1件: 46
1471Asceniv™----1件: 65
1472Ascorbic acid1件: Ascorbic acid1件: D00018 --4件: 10, 97, 206, 298
1473Ascorbic acid (Vitamin C)1件: Ascorbic acid1件: D00018 --1件: 10
1474Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)3件: Ascorbic acid,
Tocopherol,
Vitamin E		3件: D00018 ,
D02331 ,
D02332 		--1件: 206
1475Ascorbic acid vit C1件: Ascorbic acid1件: D00018 --1件: 10
1476ASCs----2件: 53, 96
1477ASCs: Adipose derived Stem Cells----1件: 96
1478Asendis----1件: 46
1479Asendis 50 mg----1件: 46
1480ASF-1096 Cream 0.25%----1件: 49
1481ASF-1096 Cream 0.5%----1件: 49
1482ASF-1096 Cream 1.0%----1件: 49
1483Asfotas Alfa----1件: 172
1484ASFOTASE ALFA1件: Asfotase alfa1件: D10595 1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172
1485Asfotase Alfa (ALXN1215)1件: Asfotase alfa1件: D10595 1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172
1486ASK Nr. 21972----1件: 5
1487ASK8007----1件: 46
1488ASP015K----2件: 46, 97
1489ASP015K hydrobromide----1件: 46
1490ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46
1491ASP1707----1件: 46
1492ASP2408----1件: 46
1493ASP2409----1件: 46
1494ASP3291----1件: 97
1495ASP3652----1件: 226
1496ASP5094----1件: 46
1497ASP6294----1件: 226
1498Asparaginase1件: Asparaginase Escherichia coli1件: D02997 --1件: 65
1499Aspergillus oryzae1件: Aspergillus oryzae---1件: 97
1500Aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 34, 46, 49, 51, 58, 86, 113, 158, 210, 231
1501Aspirin 650mg Oral Capsule1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
1502Aspirin 81mg tablet1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
1503Aspirin and meloxicam2件: Acetylsalicylic acid,
Meloxicam		2件: D00109 ,
D00969 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49
1504Aspirin Tablets1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
1505Assessment of therapy complications----1件: 60
1506Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53
1507Assigned pulmonary hypertension medication----1件: 86
1508AST-120----2件: 96, 97
1509AstroRx----1件: 2
1510ASyn Mab----1件: 6
1511AT 10----2件: 6, 85
1512AT-1501----2件: 2, 66
1513AT-GTX-501----1件: 19
1514AT1-inhibitor----1件: 218
1515AT1001----1件: 19
1516AT1001 150 mg----1件: 19
1517AT132----1件: 111
1518AT2101----1件: 19
1519AT22201件: AT2220---1件: 256
1520AT2221----1件: 256
1521AT2221 65 mg Formulated Capsules----1件: 256
1522AT845----1件: 256
1523ATA188----1件: 13
1524Atacicept1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 49, 66
1525Atacicept 150 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 49
1526Atacicept 25 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66
1527Atacicept 75 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66
1528Atacicept 75 milligram (mg)1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49
1529Atacicept150mg----1件: 66
1530Atacicept25mg----1件: 66
1531Atacicept75mg----1件: 66
1532Atacicept: with loading dose1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46
1533ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
1534Ataluren (PTC124®)1件: Ataluren1件: D09323 --1件: 299
1535Ataluren 1000 mg1件: Ataluren1件: D09323 --1件: 113
1536Ataluren 1000mg1件: Ataluren1件: D09323 --1件: 246
1537Ataluren 125 mg1件: Ataluren1件: D09323 --1件: 113
1538Ataluren 125mg1件: Ataluren1件: D09323 --1件: 246
1539Ataluren 250 mg1件: Ataluren1件: D09323 --1件: 113
1540Ataluren 250mg1件: Ataluren1件: D09323 --1件: 246
1541Atazanavir1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
1542Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		3件: D00427 ,
D01276 ,
D07471 		--1件: 265
1543Atazanavir (Reyataz)1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
1544Atazanavir/Ritonavir2件: Atazanavir,
Ritonavir		3件: D00427 ,
D01276 ,
D07471 		--1件: 265
1545ATB200----1件: 256
1546ATENOLOL1件: Atenolol1件: D00235 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167
1547Atenolol or Propranolol2件: Atenolol,
Propranolol		3件: D00235 ,
D00483 ,
D08443 		3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167
1548Atezolizumab1件: Atezolizumab1件: D10773 1件: CD274 💬2件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬1件: 85
1549ATG----4件: 13, 60, 96, 285
1550ATG (rabbit)1件: Rabbit---1件: 11
1551ATG conditioning regimen----1件: 60
1552ATG+cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60
1553ATG+Rapamune+cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60
1554ATG-F----1件: 66
1555ATG-Fresenius----1件: 60
1556Atgam1件: Antilymphocyte immunoglobulin (horse)---1件: 60
1557ATGAM plus CsA with or without Eltrombopag1件: Eltrombopag---1件: 60
1558ATH-1017----1件: 6
1559ATH434 dose level 1----1件: 17
1560ATH434 dose level 2----1件: 17
1561ATI-450----2件: 46, 106
1562ATL-25021件: ATL-2502---1件: 97
1563ATL11021件: ATL1102---1件: 13
1564ATM FOG in PD----1件: 6
1565ATN-103----1件: 46
1566ATN-103 10 mg q4wks----1件: 46
1567ATN-103 10 mg q8wks----1件: 46
1568ATN-103 30 mg q4wks----1件: 46
1569ATN-103 80 mg q4wks----1件: 46
1570ATN-103 80 mg q8wks----1件: 46
1571Atomexetine----1件: 17
1572Atomoxetine1件: Atomoxetine2件: D02574 ,
D07473 		1件: SLC6A2 💬1件: Synaptic vesicle cycle 💬4件: 6, 8, 13, 17
1573Atorvastatin1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
1574Atorvastatin 10mg1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
1575Atorvastatin 20mg1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
1576Atorvastatin Calcium2件: Atorvastatin,
Calcium		3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 97, 265
1577Atorvastatin tablet 20 mg1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 46
1578Atosiban1件: Atosiban1件: D03008 1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 118
1579ATOVAQUONE1件: Atovaquone1件: D00236 --1件: 61
1580ATR-101----2件: 75, 81
1581ATRA1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬2件: 63, 94
1582ATRASENTAN1件: Atrasentan---3件: 66, 218, 222
1583Atropina1件: Atropine5件: D00113 ,
D01077 ,
D02069 ,
D03011 ,
D03814 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
1584Atropine1件: Atropine5件: D00113 ,
D01077 ,
D02069 ,
D03011 ,
D03814 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2
1585ATV----1件: 265
1586ATX-MS-1467----1件: 13
1587Atypical Antipsychotics----1件: 6
1588ATYR19231件: ATYR1923---1件: 84
1589ATYR1923 1.0 mg/kg1件: ATYR1923---1件: 84
1590ATYR1923 3.0 mg/kg1件: ATYR1923---1件: 84
1591ATYR1923 5.0 mg/kg1件: ATYR1923---1件: 84
1592ATYR1940----1件: 113
1593AUBAGIO1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1594AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1595AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1596Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1597Aubagio®1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1598AUC of MPA measure----1件: 51
1599Audiological and ear, nose and throat examination----1件: 78
1600Augmentin1件: Clavulanic acid1件: D07711 --1件: 299
1601Aurexis----1件: 299
1602Aurexis® (tefibazumab)1件: Tefibazumab1件: D06054 --1件: 299
1603Auto Injector----1件: 46
1604Auto-Injector Device (AID)----1件: 46
1605Auto-titrating oxygen system1件: Oxygen1件: D00003 --1件: 85
1606Autoantibody Reductive Therapy----1件: 85
1607Autofluorescent detection + Injection of indocyanine green1件: Indocyanine green1件: D01342 --1件: 235
1608Autoinjector----1件: 46
1609Autologous (self) mononuclear cells derived from umbilical cord blood----1件: 211
1610Autologous adipose derived mesenchymal cells----1件: 13
1611Autologous Adipose Derived MSCs (ADMSCs)----1件: 85
1612Autologous adipose derived stem cells----1件: 46
1613Autologous ADIpose derived stromal vascular fraction----1件: 96
1614Autologous Adipose Mesenchymal Stem Cell Implantation----1件: 17
1615Autologous Adipose-derived Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 2
1616Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded----1件: 2
1617Autologous adult bone marrow mononuclear cells unexpanded----1件: 2
1618Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13
1619Autologous apoptotic cells injection----1件: 46
1620Autologous ASC----1件: 51
1621Autologous bone marrow mononuclear cell transplantation----1件: 113
1622Autologous bone marrow mononucleated cells----1件: 2
1623Autologous bone marrow transplantation----2件: 13, 28
1624Autologous Bone Marrow-Derived Mononuclear Stem Cells----1件: 13
1625Autologous bone marrow-derived stem cells----1件: 2
1626Autologous CD34+ cell transduced with G2SCID vector----1件: 65
1627AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65
1628AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19
1629Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19
1630AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20
1631Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65
1632Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65
1633Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65
1634AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65
1635Autologous CD34+HPC transplantation (HSCT)----1件: 49
1636Autologous CD34-selected peripheral blood stem cells transplant----1件: 96
1637Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13
1638Autologous cell-based delivery----1件: 211
1639Autologous EBV specific CTL infusion----1件: 49
1640Autologous EPCs transfected----1件: 86
1641Autologous EPCs transfected with human eNOS----1件: 86
1642Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65
1643Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA----1件: 20
1644Autologous Hematopoietic Stem Cell----1件: 13
1645Autologous hematopoietic stem cell transplant----1件: 13
1646Autologous Hematopoietic Stem Cell Transplantation----7件: 11, 13, 14, 28, 49, 51, 84
1647Autologous hematopoietic stem cell transplantation (ASCT)----1件: 28
1648Autologous hematopoietic stem cells----1件: 13
1649Autologous Human Placental Cord Blood Mononuclear Cells----1件: 211
1650Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70----1件: 46
1651Autologous Mesenchymal Cell Product----1件: 13
1652Autologous mesenchymal stem cell transplantation----1件: 13
1653Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46
1654Autologous Mesenchymal stem cells (MSCs)----1件: 2
1655Autologous mesenchymal stem cells derived from bone marrow----1件: 85
1656Autologous mesenchymal stromal cell----2件: 96, 298
1657Autologous MSC-NTF cells----1件: 2
1658Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population----1件: 96
1659Autologous peripheral blood stem cell transplantation----8件: 28, 40, 41, 42, 45, 46, 49, 283
1660Autologous Plasmablasts----1件: 19
1661Autologous Regulatory ?-cells----1件: 51
1662Autologous serum----1件: 53
1663Autologous Serum 20%----1件: 53
1664Autologous Serum 50%----1件: 53
1665Autologous Stem Cell----1件: 8
1666Autologous stem cell transplant----4件: 28, 53, 56, 96
1667Autologous Stem Cell Transplantation----4件: 13, 28, 56, 96
1668Autologous Stem Cells----2件: 13, 51
1669Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51
1670Autologous Stromal Vascular Fraction (SVF)----1件: 85
1671Autologous stromal vascular fraction cells----1件: 46
1672AUTOLOGOUS T-LYMPHOCYTES----1件: 13
1673Autologous T-regulatory lymphocytes----1件: 2
1674Autologous Tissue-Engineered Vascular Graft----1件: 210
1675Autologous Umbilical Cord Blood----2件: 211, 294
1676Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)----1件: 13
1677Autologous-autologous tandem hematopoietic stem cell transplantation----1件: 28
1678Automated abdominal binder----1件: 17
1679AV-1011件: AV-101---2件: 6, 86
1680AV1451 Tau----1件: 127
1681AV605----1件: 13
1682Avacincaptad pegol1件: Avacincaptad pegol---1件: 301
1683Avacopan1件: Avacopan1件: D11093 1件: C5AR1 💬6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬3件: 43, 44, 222
1684Avalglucosidase Alfa1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1685Avalglucosidase alfa (GZ402666)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1686Avalglucosidase Alfa (NeoGAA)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1687Avalglucosidase alfa GZ4026661件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1688Avalglucosidase alfa(GZ402666)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1689Avalglucosidasi alfa----1件: 256
1690AVALOX - 400----1件: 6
1691Avandia administration for 6-12 weeks----1件: 265
1692AVASTIN1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227
1693AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227
1694Avatrombopag1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬2件: 60, 63
1695Avatrombopag (proposed)1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1696Avatrombopag 20 MG1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 60
1697AVATROMBOPAG MALEATE1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1698Avatrombopag tablets1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1699AVB-114----1件: 96
1700AVB-S6-500----1件: 66
1701AVCN583601 (3% Cannabidiol cream)1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 36
1702Avdoralimab1件: Avdoralimab---1件: 162
1703Avdoralimab (IPH5401)1件: Avdoralimab---1件: 162
1704AVE8112----1件: 6
1705AVE9897----1件: 46
1706Avelox- Moxifloxacin1件: Moxifloxacin2件: D00874 ,
D08237 		--1件: 46
1707Avelox®1件: Moxifloxacin2件: D00874 ,
D08237 		--1件: 46
1708AVI-4658----1件: 113
1709AVI-4658 (Eteplirsen)1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
1710AVI-4658 (PMO)----1件: 113
1711AVI-4658 for Injection----1件: 113
1712Avian polyclonal IgY antibody against PA----1件: 299
1713Avibactam1件: Avibactam---1件: 299
1714AVID200----1件: 51
1715Aviptadil1件: Aviptadil1件: D12127 --5件: 49, 51, 84, 85, 86
1716Aviptadil, 66 microgram/mL1件: Aviptadil1件: D12127 --1件: 85
1717AVONEX1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97
1718Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1719Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1720AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1721Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1722AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1723Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1724AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1725Avonex and Topamax1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1726AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1727Avonex prefilled syringe via manual IM injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1728AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1729Avonex/Betaseron/Copaxone/Rebif3件: Glatiramer,
Interferon beta-1a,
Interferon beta-1b		3件: D00746 ,
D04318 ,
D04554 		22件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬		44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13
1730Avonex/Zocor1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1731AVONEX®1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1732Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1733AVP-923----3件: 2, 6, 13
1734AVP-923-45----1件: 6
1735AVR-RD-01----1件: 19
1736AVR-RD-02----1件: 19
1737AVX 470----1件: 97
1738AVXS-101----1件: 3
1739AVXS-101 (previously known as scAAV9.CB.SMN)----1件: 3
1740AX----1件: 19
1741AX 250----1件: 19
1742Axially Oscillating Sphere dry powder inhaler (AOS DPI)----1件: 86
1743Axitinib1件: Axitinib1件: D03218 3件: FLT1,
FLT4,
KDR 💬		15件: Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34
1744AXO-AAV-GM2 High Dose----1件: 19
1745AXO-AAV-GM2 Low Dose----1件: 19
1746AXO-AAV-GM2 Middle Dose----1件: 19
1747AXO-AAV-GM2 Starting Dose----1件: 19
1748AZA----4件: 11, 40, 96, 97
1749AZA capsules----1件: 96
1750AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL----1件: 97
1751AZAFOR 50mg----1件: 97
1752AZAPRED----1件: 85
1753Azathioprin----2件: 46, 96
1754Azathioprin-ratiopharm 25 mg----1件: 96
1755Azathioprin-ratiopharm 25mg Filmtabletten----1件: 96
1756Azathioprin-ratiopharm 50 mg Filmtabletten----1件: 96
1757Azathioprin-ratiopharm® 25 mg Filmtabletten----1件: 44
1758Azathioprine1件: Azathioprine2件: D00238 ,
D03033 		--21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
1759Azathioprine (AZA)1件: Azathioprine2件: D00238 ,
D03033 		--3件: 13, 19, 97
1760Azathioprine (AZA) caps1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1761Azathioprine (AZA) or 6-mercaptopurine (6-MP)2件: Azathioprine,
Mercaptopurine		4件: D00161 ,
D00238 ,
D03033 ,
D04931 		1件: HPRT1 💬3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬2件: 96, 97
1762Azathioprine (Imuran) 50 mg Overencapsulated Tablet1件: Azathioprine2件: D00238 ,
D03033 		--1件: 97
1763Azathioprine - ratiopharm 50 mg1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1764Azathioprine / 6 Mercaptopurine2件: Azathioprine,
Mercaptopurine		4件: D00161 ,
D00238 ,
D03033 ,
D04931 		1件: HPRT1 💬3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬1件: 96
1765Azathioprine 25 mg1件: Azathioprine2件: D00238 ,
D03033 		--1件: 44
1766Azathioprine and Allopurinol2件: Allopurinol,
Azathioprine		3件: D00224 ,
D00238 ,
D03033 		1件: XDH 💬5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬1件: 97
1767AZATHIOPRINE BP1件: Azathioprine2件: D00238 ,
D03033 		--1件: 97
1768Azathioprine in case of endoscopic recurrence1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1769Azathioprine individualised dose1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1770Azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		4件: D00161 ,
D00238 ,
D03033 ,
D04931 		1件: HPRT1 💬3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬2件: 96, 97
1771Azathioprine or adalimumab and infliximab3件: Adalimumab,
Azathioprine,
Infliximab		4件: D00238 ,
D02597 ,
D02598 ,
D03033 		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
1772Azathioprine OR Mesalazine2件: Azathioprine,
Mesalazine		3件: D00238 ,
D00377 ,
D03033 		--1件: 96
1773AZATHIOPRINE or METHOTREXATE2件: Azathioprine,
Methotrexate		4件: D00142 ,
D00238 ,
D02115 ,
D03033 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96
1774Azathioprine or Mycophenolate mofetil3件: Azathioprine,
Mycophenolate mofetil,
Mycophenolic acid		6件: D00238 ,
D00752 ,
D03033 ,
D05094 ,
D05095 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬1件: 162
1775Azathioprine weight-based dose1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1776Azathioprine+enteral nutrition1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1777Azathioprine/prednisone2件: Azathioprine,
Prednisone		3件: D00238 ,
D00473 ,
D03033 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 85
1778Azatioprina1件: Azathioprine2件: D00238 ,
D03033 		--3件: 13, 96, 97
1779AZATIOPRINA ASPEN - 50 COMPRESSE1件: Azathioprine2件: D00238 ,
D03033 		--1件: 96
1780AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine2件: D00238 ,
D03033 		--1件: 13
1781AZD0328----1件: 6
1782AZD0530----1件: 272
1783AZD0530 Difumarate----1件: 272
1784AZD1236----1件: 299
1785AZD2014----1件: 34
1786AZD3241----2件: 6, 17
1787AZD3241 100mg----1件: 17
1788AZD3241 300 mg BID----1件: 6
1789AZD3241 300mg----1件: 17
1790AZD3241 600 mg BID----1件: 6
1791AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6
1792AZD3241 ER formulation 1----1件: 6
1793AZD3241 Extended release tablets 100 mg1件: Manganese citrate---1件: 6
1794AZD3241 Extended release tablets 25 mg1件: Manganese citrate---1件: 6
1795AZD4017----1件: 75
1796AZD4017 and prednisolone1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
1797AZD4831----1件: 86
1798AZD5055----1件: 85
1799AZD5634----1件: 299
1800AZD5634 for infusion----1件: 299
1801AZD5634 for inhalation----1件: 299
1802AZD5672----1件: 46
1803AZD6244----1件: 34
1804AZD7325----1件: 206
1805AZD7325 (High-Dose)----1件: 206
1806AZD7325 (Low-Dose)----1件: 206
1807AZD7986----2件: 44, 299
1808AZD9056----2件: 46, 96
1809AZD9056 hydrochloride----1件: 46
1810AZD9567----1件: 46
1811AZD9567 10 mg----1件: 46
1812AZD9567 125 mg----1件: 46
1813AZD9567 155 mg----1件: 46
1814AZD9567 20 mg----1件: 46
1815AZD9567 40 mg----1件: 46
1816AZD9567 80 mg----1件: 46
1817AZD9567 Monohydrat----1件: 46
1818AZD9567 monohydrate----1件: 46
1819AZD9668----1件: 299
1820Azilect1件: Rasagiline3件: D02562 ,
D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17
1821AZILECT 1 mg comprimidos1件: Rasagiline3件: D02562 ,
D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17
1822Azilect 1mg1件: Rasagiline3件: D02562 ,
D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1823AZILECT®1件: Rasagiline3件: D02562 ,
D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1824AZILECT® 1 mg Tabletten1件: Rasagiline3件: D02562 ,
D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 2
1825Azithromycin1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
1826Azithromycin (Zitromax°)1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 228
1827Azithromycin + Metronidazole2件: Azithromycin,
Metronidazole		6件: D00409 ,
D02134 ,
D05016 ,
D05017 ,
D06390 ,
D07486 		--1件: 96
1828Azithromycin + N-acetylcystein + inhaled corticosteroid1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 228
1829Azithromycin 250 mg tablets1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
1830Azithromycin 250Mg Capsule1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 84
1831Azithromycin 500 mg film-coated tablet1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
1832AZITHROMYCIN DIHYDRATE1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--2件: 228, 299
1833Azithromycin monohydrate1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 84
1834AZITHROMYCINE1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 228
1835AZITHROMYCINE 250 mg1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 228
1836AZLI----1件: 299
1837AZLI 75 mg three times a day (TID)----1件: 299
1838AZLI 75 mg three times daily (TID)----1件: 299
1839AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299
1840AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299
1841AZM----1件: 228
1842AZP-3601----1件: 235
1843AZP-531----1件: 193
1844AZP2006 oral solution----1件: 5
1845AZT----3件: 94, 265, 325
1846AZT/3TC----1件: 265
1847Aztreonam1件: Aztreonam2件: D00240 ,
D06558 		--2件: 228, 299
1848Aztreonam for Inhalation (AI)1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
1849Aztreonam for Inhalation Solution1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
1850Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
1851AZTREONAM LYSINE2件: Aztreonam,
Lysine		3件: D00240 ,
D02304 ,
D06558 		--1件: 299
1852Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		3件: D00240 ,
D02304 ,
D06558 		--1件: 299
1853Aztreonam Lysine for Inhalation (AZLI)2件: Aztreonam,
Lysine		3件: D00240 ,
D02304 ,
D06558 		--1件: 228
1854Aztreonam solución para inhalación1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
1855Aztreonan lysine1件: Lysine1件: D02304 --1件: 299
1856Aún no establecido----1件: 53